Sasada Tetsuro 笹田哲朗

… Alternative Names

笹田哲朗ササダテツロウ

SASADA Tetsuro 笹田哲朗

SASADA Teturo 笹田哲朗

Less

Researcher Number	70293967
Other IDs
Affiliation (Current)	2025: 地方独立行政法人神奈川県立病院機構神奈川県立がんセンター(臨床研究所), がんワクチン・免疫センター, 部長
Affiliation (based on the past Project Information) *help	2021 – 2023: 地方独立行政法人神奈川県立病院機構神奈川県立がんセンター(臨床研究所), がんワクチン・免疫センター, 部長 2019: 地方独立行政法人神奈川県立病院機構神奈川県立がんセンター(臨床研究所), がんワクチン・免疫センター, 部長 2014 – 2018: 地方独立行政法人神奈川県立病院機構神奈川県立がんセンター(臨床研究所), がんワクチンセンター, 部長 2010 – 2013: 久留米大学, 医学部, 准教授 2006: 田附興風会, 研究員 … More 2005: (財)田附興風会, 医学研究所・第2研究部, 主任研究員 2003 – 2004: 財団法人田附興風会, 医学研究所・第2研究部, 主任研究員 2002: The Tazuke-Kofukai, Medical Research Institute Chief Researcher, 医学研究所・第2研究部, 研究員 2002: 財団法人田附興風会, 医学研究所第2研究部, 研究員 Less
Review Section/Research Field	Principal Investigator General surgery / Digestive surgery / Medium-sized Section 56:Surgery related to the biological and sensory functions and related fields / Basic Section 55010:General surgery and pediatric surgery-related / Medium-sized Section 50:Oncology and related fields Except Principal Investigator Basic Section 55010:General surgery and pediatric surgery-related / General surgery
Keywords	Principal Investigator ネオアンチゲン / 免疫療法 / 遺伝子変異 / ペプチドミクス解析 / オルガノイド / 抗腫瘍効果 / 個別化治療 / がん免疫療法 / 免疫反応 / 腫瘍免疫 … More / ペプチド / シングルセル解析 / T細胞受容体 / 質量分析計 / HLA分子 / がん免疫治療 / Ｂ細胞受容体 / Ｂ細胞 / レパトア / B細胞受容体 / 有害事象 / 免疫チェックポイント阻害剤 / バイオマーカー / 抗原 / B細胞受容体レパトア / B細胞 / 抗PD-1抗体 / 細胞表面マーカー / ゼノグラフト / 異所性リンパ様組織 / サイトカイン / ケモカイン / 腫瘍浸潤免疫細胞 / Tumor antigen / Proteome / Pancreatic cancer / 癌抗原 / プロテオーム / 膵臓癌 / Ｔ細胞 / 免疫原性 / Ｔ細胞エピトープ / 上皮成長因子受容体（EGFR） / KRAS / 上皮成長因子受容体（EGFR) / ペプチドワクチン / T細胞エピトープ / 突然変異遺伝子 / 腫瘍免疫学 / 細胞傷害性T細胞(CTL) / 癌幹細胞 / 上皮間葉移行(EMT) / 癌ワクチン / 免疫学 / 癌 / ワクチン / リンパ管新生 … More Except Principal Investigator Surgical Stress / 低侵襲 / 末梢血可溶性因子 / 機械学習 / 層別化 / がん免疫療法 / biomarker / machine learning / cytokine / ICI / Drug Resistance / Chemotherapy / Thioredxin / Natural Killer Cell / Peripheral Blood Lymphocytes / Mitochondrial Membrane Potential / 消化器癌 / 腫瘍増殖 / CD4^+CD25^+T cell / 薬剤耐性 / 化学療法 / チオレドキシン / NK細胞 / 末梢血リンパ球 / ミトコンドリア膜電位 / 外科的侵襲 Less

ペプチドミクス解析とシングルセルTCR解析を用いたネオアンチゲン同定法の確立Principal Investigator
- Principal Investigator
  
  笹田哲朗
- Project Period (FY)
  2023 – 2024
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 56:Surgery related to the biological and sensory functions and related fields
- Research Institution
  Kanagawa Cancer Center Research Institute
Establishment of an AI-based platform for predicting response to cancer immunotherapy
- Principal Investigator
  
  魏菲菲
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55010:General surgery and pediatric surgery-related
- Research Institution
  Kanagawa Cancer Center Research Institute
Identification of cancer-specific neoantigens in organoid culturePrincipal Investigator
- Principal Investigator
  
  Sasada Tetsuro
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 55010:General surgery and pediatric surgery-related
- Research Institution
  Kanagawa Cancer Center Research Institute
Analysis of B cell repertoires and their antigen specificity in peripheral blood from cancer patients undergoing anti-PD-1 antibody therapy.Principal Investigator
- Principal Investigator
  
  Sasada Tetsuro
- Project Period (FY)
  2018 – 2019
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 50:Oncology and related fields
- Research Institution
  Kanagawa Cancer Center Research Institute
Analysis of neoantigen-specific anti-tumor immune responses and its clinical application for personalized cancer immunotherapyPrincipal Investigator
- Principal Investigator
  
  Sasada Tetsuro
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  General surgery
- Research Institution
  Kanagawa Cancer Center Research Institute
Induction of tumor infiltrating immune cells through regulation of tumor microenvironment and its application for novel cancer immunotherapyPrincipal Investigator
- Principal Investigator
  
  Sasada Tetsuro
- Project Period (FY)
  2016 – 2017
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  General surgery
- Research Institution
  Kanagawa Cancer Center Research Institute
Comprehensive analysis of immune responses to tumor-specific genetic mutations and its application to novel cancer immunotherapy.Principal Investigator
- Principal Investigator
  
  Sasada Tetsuro
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  General surgery
- Research Institution
  Kanagawa Cancer Center Research Institute
Development of Novel Cancer Immunotherapy Targeting Mutated Genes: Identification of Antigen Epitopes Derived from the Mutated KRAS and EGFR Genes.Principal Investigator
- Principal Investigator
  
  SASADA Tetsuro
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General surgery
- Research Institution
  Kurume University
上皮間葉移行(EMT)を起こした幹細胞様癌細胞を標的とした新しい免疫療法の開発Principal Investigator
- Principal Investigator
  
  笹田哲朗
- Project Period (FY)
  2010 – 2011
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Research Field
  
  General surgery
- Research Institution
  Kurume University
リンパ管新生因子を標的としたワクチン療法による癌リンパ節転移予防・治療法の開発Principal Investigator
- Principal Investigator
  
  笹田哲朗
- Project Period (FY)
  2005 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Tazuke Kofukai Medical Research Institute
Idenification of tumor antigens in pancreatic cancer by proteomic analysis.Principal Investigator
- Principal Investigator
  
  SASADA Tetsuro
- Project Period (FY)
  2003 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  The Tazuke Kofukai
Analysis of the effect of surgical stress on the biological defense system and cancer promotion
- Principal Investigator
  
  TAKABAYASHI Arimichi
- Project Period (FY)
  2001 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  General surgery
- Research Institution
  THE TAZUKEKOFUKAI MEDICAL RESEARCH INSTITUTE

[Book] プレシジョン・メディシン　～ビッグデータの構築・分析から臨床応用・課題まで～.　（第2編第3章第3節）変異遺伝子を標的とした個別化がん免疫療法の開発.2018
- Author(s)
  紅露拓, 笹田哲朗
- Total Pages
  406
- Publisher
  エヌ・ティー・エス
- ISBN
- Data Source
  KAKENHI-PROJECT-17H04278
[Book] プレシジョン・メディシン　～ビッグデータの構築・分析から臨床応用・課題まで～.　 (第2編第3章第3節) 変異遺伝子を標的とした個別化がん免疫療法の開発.2018
- Author(s)
  紅露拓，笹田哲朗.
- Total Pages
  406
- Publisher
  エヌ・ティー・エス
- ISBN
- Data Source
  KAKENHI-PROJECT-18K19490
[Book] がん治療で起こる副作用・合併症の治療法と薬剤開発.　 (第4章 11節) がんワクチン2018
- Author(s)
  和田聡, 笹田哲朗
- Total Pages
  508
- Publisher
  技術情報協会
- ISBN
  9784861047237
- Data Source
  KAKENHI-PROJECT-18K19490
[Book] がん治療で起こる副作用・合併症の治療法と薬剤開発.　（第4章 11節）がんワクチン2018
- Author(s)
  和田聡, 笹田哲朗
- Total Pages
  508
- Publisher
  技術情報協会
- ISBN
  9784861047237
- Data Source
  KAKENHI-PROJECT-17H04278
[Book] Tumor immunotherapy of esophageal and gastric cancers. (In Rezaei N ed. Cancer Immunology: Immunotherapy for Organ-Specific Tumors.)2015
- Author(s)
  Toh U, Sasada T, Takahashi R, lwakuma N, Shirouzu K, Itoh K.
- Total Pages
  485
- Publisher
  Springer-Verlag GmbH
- Data Source
  KAKENHI-PROJECT-26293293
[Book] Personalized peptide vaccine as a novel immunotherapy against advanced cancer, Molecular Vaccines - From Prophylaxis to Therapy2013
- Author(s)
  Komatsu N, Matsueda S, Noguchi M, Yamada A, Itoh K, Sasada T.
- Publisher
  In Giese Med
- Data Source
  KAKENHI-PROJECT-23591913
[Book] Molecular Vaccines - From Prophylaxis to Therapy.2013
- Author(s)
  Komatsu N, Matsueda S, Noguchi M, Yamada A, Itoh K, Sasada T
- Total Pages
  447
- Publisher
  Springer-Verlag Wien
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors2024
- Author(s)
  Nagasaka Hirotaka、Kishida Takeshi、Kouro Taku、Igarashi Yuka、Takebe Shinichi、Yamamoto Shotaro、Kondo Takuya、Koizumi Mitsuyuki、Terao Hideyuki、Suzuki Takahisa、Nakaigawa Noboru、Himuro Hidetomo、Wei Feifei、Sasada Tetsuro
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: - Issue: 6 Pages: 832-839
- DOI
  10.1007/s10147-024-02477-4
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08724, KAKENHI-PROJECT-19K09676, KAKENHI-PROJECT-21H02995
[Journal Article] Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors2024
- Author(s)
  Nakahara Yoshiro、Kouro Taku、Motoyama Satoru、Miura Masatomo、Fujita Kazuma、Igarashi Yuka、Higashijima Naoko、Matsuo Norikazu、Himuro Hidetomo、Wei Feifei、Horaguchi Shun、Tsuji Kayoko、Mano Yasunobu、Komahashi Mitsuru、Saito Haruhiro、Azuma Koichi、Sasada Tetsuro
- Journal Title
  
  Frontiers in Cell and Developmental Biology
  
  Volume: -
- DOI
  10.3389/fcell.2023.1324898
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08724, KAKENHI-PROJECT-21H02995, KAKENHI-PROJECT-23H05274
[Journal Article] Novel chimeric antigen receptor‐expressing T cells targeting the malignant mesothelioma‐specific antigen sialylated HEG12024
- Author(s)
  Kouro Taku、Higashijima Naoko、Horaguchi Shun、Mano Yasunobu、Kasajima Rika、Xiang Huihui、Fujimoto Yuki、Kishi Hiroyuki、Hamana Hiroshi、Hoshino Daisuke、Himuro Hidetomo、Matsuura Rieko、Tsuji Shoutaro、Imai Kohzoh、Sasada Tetsuro
- Journal Title
  
  International Journal of Cancer
  
  Volume: 154 Issue: 10 Pages: 1828-1841
- DOI
  10.1002/ijc.34843
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21H02995
[Journal Article] Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation2024
- Author(s)
  Wei F, Kouro T, Nakamura Y, Ueda H, Iiizumi S, Hasegawa K, Asahina Y, Kishida T, Morinaga S, Himuro H, Horaguchi S, Tsuji K, Mano Y, Nakamura N, Kawamura T, Sasada T.
- Journal Title
  
  Comput Struct Biotechnol J
  
  Volume: 23 Pages: 859-869
- DOI
  10.1016/j.csbj.2024.01.023
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K18346, KAKENHI-PROJECT-22K08724, KAKENHI-PROJECT-21H02995
[Journal Article] Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma2023
- Author(s)
  Shibata Yosuke、Kishida Takeshi、Kouro Taku、Wei Feifei、Igarashi Yuka、Himuro Hidetomo、Noguchi Takeaki、Koizumi Mitsuyuki、Suzuki Takahisa、Osaka Kimito、Saigusa Yusuke、Sasada Tetsuro
- Journal Title
  
  Frontiers in Pharmacology
  
  Volume: 14 Pages: 1269935-1269935
- DOI
  10.3389/fphar.2023.1269935
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08724, KAKENHI-PROJECT-21H02995
[Journal Article] CAR-T細胞の疲弊メカニズムとその対策.2023
- Author(s)
  紅露拓，笹田哲朗
- Journal Title
  
  実験医学増刊号
  
  Volume: 41 Pages: 188-192
- Data Source
  KAKENHI-PROJECT-21H02995
[Journal Article] Circulating cytokine signatures as a soluble biomarker of immune checkpoint inhibitor therapy in non-small-cell lung cancer2023
- Author(s)
  Wei Feifei、Sasada Tetsuro
- Journal Title
  
  Genes & Immunity
  
  Volume: 25 Issue: 1 Pages: 89-91
- DOI
  10.1038/s41435-023-00236-5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K08724, KAKENHI-PROJECT-21H02995
[Journal Article] Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors.2023
- Author(s)
  Hidetomo Himuro, Yoshiro Nakahara, Yuka Igarashi, Taku Kouro, Naoko Higashijima, Norikazu Matsuo, Shuji Murakami, Feifei Wei, Shun Horaguchi, Kayoko Tsuji, Yasunobu Mano, Haruhiro Saito, Koichi Azuma, Tetsuro Sasada
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: na Issue: 8 Pages: 2829-2840
- DOI
  10.1007/s00262-023-03464-w
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08724, KAKENHI-PROJECT-21H02995
[Journal Article] Machine learning for prediction of immunotherapeutic outcome in non-small-cell lung cancer based on circulating cytokine signatures2023
- Author(s)
  Wei Feifei、Azuma Koichi、Nakahara Yoshiro、Saito Haruhiro、Matsuo Norikazu、Tagami Tomoyuki、Kouro Taku、Igarashi Yuka、Tokito Takaaki、Kato Terufumi、Kondo Tetsuro、Murakami Shuji、Usui Ryo、Himuro Hidetomo、Horaguchi Shun、Tsuji Kayoko、Murotani Kenta、Ban Tatsuma、Tamura Tomohiko、Miyagi Yohei、Sasada Tetsuro
- Journal Title
  
  Journal for ImmunoTherapy of Cancer
  
  Volume: 11 Issue: 7 Pages: e006788-e006788
- DOI
  10.1136/jitc-2023-006788
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08724, KAKENHI-PROJECT-21H02954, KAKENHI-PROJECT-21H02995
[Journal Article] A phase 1 trial of <scp>NY‐ESO</scp> ‐1‐specific <scp>TCR</scp> ‐engineered T‐cell therapy combined with a lymph node‐targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma2023
- Author(s)
  Ishihara Mikiya、Nishida Yoshihiro、Kitano Shigehisa、Kawai Akira、Takada Kohichi、Emori Makoto、Kageyama Shinichi、Shiku Hiroshi
- Journal Title
  
  International Journal of Cancer
  
  Volume: 152 Issue: 12 Pages: 2554-2566
- DOI
  10.1002/ijc.34453
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08080, KAKENHI-PROJECT-21H02995, KAKENHI-PROJECT-20K16411, KAKENHI-PROJECT-21K19561, KAKENHI-PROJECT-21K06690, KAKENHI-PROJECT-23K08700, KAKENHI-PROJECT-21K08682, KAKENHI-PROJECT-22K07277, KAKENHI-PROJECT-23K24180
[Journal Article] 腫瘍細胞からネットワークへ：遺伝子変異とサイトカインネットワークによる腫瘍免疫微小環境の形成と制御.2022
- Author(s)
  魏菲菲，笹田哲朗.
- Journal Title
  
  医学のあゆみ
  
  Volume: 281 Pages: 374-380
- Data Source
  KAKENHI-PROJECT-21H02995
[Journal Article] 腫瘍細胞からネットワークへ－遺伝子変異とサイトカインネットワークによる腫瘍微小環境の形成と制御2022
- Author(s)
  魏菲菲、笹田哲朗
- Journal Title
  
  医学のあゆみ
  
  Volume: 281 Pages: 374-380
- Data Source
  KAKENHI-PROJECT-22K08724
[Journal Article] Clinical significance of plasma-free amino acids and tryptophan metabolites in patients with non-small cell lung cancer receiving PD-1 inhibitor: a pilot cohort study for developing a prognostic multivariate model2022
- Author(s)
  Azuma Koichi#、Xiang Huihui#、Tagami Tomoyuki、Kasajima Rika、Kato Yumiko、Karakawa Sachise、Kikuchi Shinya、Imaizumi Akira、Matsuo Norikazu、Ishii Hidenobu、Tokito Takaaki、Kawahara Akihiko、Murotani Kenta、Sasada Tetsuro、Miyagi Yohei、Hoshino Tomoaki (# Contributed equally)
- Journal Title
  
  Journal for ImmunoTherapy of Cancer
  
  Volume: 10 Issue: 5 Pages: e004420-e004420
- DOI
  10.1136/jitc-2021-004420
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K16585, KAKENHI-PROJECT-21H02995
[Journal Article] Evaluation of X-ray and carbon-ion beam irradiation with chemotherapy for the treatment of cervical adenocarcinoma cells in 2D and 3D cultures2022
- Author(s)
  Sekihara Kazumasa、Himuro Hidetomo、Saito Nao、Ota Yukihide、Kouro Taku、Kusano Yohsuke、Minohara Shinichi、Hirayama Ryoichi、Katoh Hiroyuki、Sasada Tetsuro、Hoshino Daisuke
- Journal Title
  
  Cancer Cell International
  
  Volume: 22 Issue: 1 Pages: 391-391
- DOI
  10.1186/s12935-022-02810-9
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K18202, KAKENHI-PROJECT-21H02995, KAKENHI-PROJECT-19K19206
[Journal Article] Exhaustion of CAR T cells: potential causes and solutions.2022
- Author(s)
  Kouro T, Himuro H, Sasada T.
- Journal Title
  
  J Transl Med.
  
  Volume: 20 Issue: 1 Pages: 239-239
- DOI
  10.1186/s12967-022-03442-3
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21H02995
[Journal Article] NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome2022
- Author(s)
  Ishihara M, Kitano S, Kageyama S, Miyahara Y, Yamamoto N, Kato H, Mishima H, Hattori H, Funakoshi T, Kojima T, Sasada T, Sato E, Okamoto S, Tomura D, Nukaya I, Chono H, Mineno J, Kairi MF, Diem Hoang Nguyen P, Simoni Y, Nardin A, Newell E, Fehlings M, Ikeda H, Watanabe T, Shiku H.
- Journal Title
  
  J Immunother Cancer
  
  Volume: 10 Issue: 6 Pages: e003811-e003811
- DOI
  10.1136/jitc-2021-003811
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K08682, KAKENHI-PROJECT-22K08876, KAKENHI-PROJECT-22K19532, KAKENHI-PROJECT-21H02990, KAKENHI-PROJECT-21H02995, KAKENHI-PROJECT-23K24180
[Journal Article] Clinical significance of peripheral TCR and BCR repertoire diversity in EGFR/ALK wild-type NSCLC treated with anti-PD-1 antibody2021
- Author(s)
  Nakahara Yoshiro、Matsutani Takaji、Igarashi Yuka、Matsuo Norikazu、Himuro Hidetomo、Saito Haruhiro、Yamada Kouzo、Murotani Kenta、Hoshino Tomoaki、Azuma Koichi、Sasada Tetsuro
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: なし Issue: 10 Pages: 2881-2892
- DOI
  10.1007/s00262-021-02900-z
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K19867, KAKENHI-PROJECT-20K16812, KAKENHI-PROJECT-19K08637, KAKENHI-PROJECT-21H02995, KAKENHI-PROJECT-16H06277
[Journal Article] Possible Role of Cytochrome P450 1B1 in the Mechanism of Gemcitabine Resistance in Pancreatic Cancer.2021
- Author(s)
  Yada E, Kasajima R, Niida A, Imoto S, Miyano S, Miyagi Y, Sasada T, Wada S.
- Journal Title
  
  Biomedicines
  
  Volume: 9 Issue: 10 Pages: 1396-1396
- DOI
  10.3390/biomedicines9101396
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21H02995
[Journal Article] High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.2020
- Author(s)
  Ohkuma R, Yada E, Ishikawa S, Komura D, Ishizaki H, Tamada K, Kubota Y, Hamada K, Ishida H, Hirasawa Y, Ariizumi H, Satoh E, Shida M, Watanabe M, Onoue R, Ando K, Tsurutani J, Yoshimura K, Yokobori T, Sasada T, Aoki T, Murakami M, Norose T, Ohike N, Takimoto M, Izumizaki M, Kobayashi S, Tsunoda T, Wada S.
- Journal Title
  
  PLoS One
  
  Volume: 10 Issue: 1 Pages: e0226707-e0226707
- DOI
  10.1371/journal.pone.0226707
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08610, KAKENHI-PROJECT-19K07320, KAKENHI-PROJECT-19K12848, KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-17H04992, KAKENHI-PROJECT-18K19490, KAKENHI-PROJECT-20K17001
[Journal Article] Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients2020
- Author(s)
  Suekane Shigetaka、Yutani Shigeru、Yamada Akira、Sasada Tetsuro、Matsueda Satoko、Takamori Shinzo、Toh Uhi、Kawano Kouichiro、Yoshiyama Koichi、Sakamoto Shinjiro、Sugawara Shunichi、Komatsu Nobukazu、Yamada Teppei、Naito Masayasu、Terasaki Mizuhiko、Mine Takashi、Itoh Kyogo、Shichijo Shigeki、Noguchi Masanori
- Journal Title
  
  International Journal of Oncology
  
  Volume: 56 Pages: 1479-1489
- DOI
  10.3892/ijo.2020.5019
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09182, KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-18K19490
[Journal Article] Distribution of Regulatory T-Cells and Other Phenotypes of T-Cells in Tumors and Regional Lymph Nodes of Colorectal Cancer Patients.2020
- Author(s)
  Kazama K, Otake J, Satoyoshi T, Shiozawa M, Sugano N, Sato S, Atsumi Y, Kano K, Murakawa M, Maezawa Y, Hashimoto I, Numata M, Oshima T, Yukawa N, Rino Y, Sasada T, Masuda M.
- Journal Title
  
  In Vivo.
  
  Volume: 34 Issue: 2 Pages: 849-856
- DOI
  10.21873/invivo.11848
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-18K19490, KAKENHI-PROJECT-16H06277
[Journal Article] Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial2020
- Author(s)
  Noguchi Masanori、Arai Gaku、Egawa Shin、Ohyama Chikara、Naito Seiji、Matsumoto Kazumasa、Uemura Hirotsugu、Nakagawa Masayuki、Nasu Yasutomo、Eto Masatoshi、Suekane Shigetaka、Sasada Tetsuro、Shichijo Shigeki、Yamada Akira、Kakuma Tatsuyuki、Itoh Kyogo
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: 69 Issue: 5 Pages: 847-857
- DOI
  10.1007/s00262-020-02498-8
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09182, KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-18K19490
[Journal Article] Prospects for a personalized peptide vaccine against lung cancer.2019
- Author(s)
  Nakahara Y, Kouro T, Igarashi Y, Kawahara M, Sasada T.
- Journal Title
  
  Expert Rev Vaccines.
  
  Volume: 18 Issue: 7 Pages: 703-709
- DOI
  10.1080/14760584.2019.1635461
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-18K19490, KAKENHI-PROJECT-16H06277
[Journal Article] Association between soluble immune mediators and tumor responses in patients with nonsmall cell lung cancer treated with anti-PD-1 inhibitor.2019
- Author(s)
  Matsuo N, Azuma K, Hattori S, Ohtake J, Kawahara A, Ishii H, Tokito T, Yamada K, Shibata Y, Shimokawaji T, Kondo T, Kato T, Saito H, Yamada K, Sasada T, Hoshino T.
- Journal Title
  
  Int J Cancer.
  
  Volume: 144 Issue: 5 Pages: 1170-1179
- DOI
  10.1002/ijc.31923
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K19490, KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-16K09595, KAKENHI-PROJECT-16K09596, KAKENHI-PROJECT-16H06277
[Journal Article] Assessment of soluble immune mediators as potential biomarkers during immune checkpoint inhibitor therapy.2019
- Author(s)
  Matsuo N, Azuma K, Sasada T.
- Journal Title
  
  Oncotarget.
  
  Volume: 10 Issue: 20 Pages: 1866-1867
- DOI
  10.18632/oncotarget.26749
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K19490, KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-16H06277
[Journal Article] がん免疫療法のバイオマーカーの現状および今後の展望.2019
- Author(s)
  松尾規和，笹田哲朗
- Journal Title
  
  実験医学増刊「がん免疫療法の個別化を支える新・腫瘍免疫学」
  
  Volume: 37 Pages: 180-188
- Data Source
  KAKENHI-PROJECT-18K19490
[Journal Article] Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial2019
- Author(s)
  Shimizu Yasuhiro、Yoshikawa Toshiaki、Kojima Takashi、Shoda Kayoko、Nosaka Kazuto、Mizuno Shoichi、Wada Satoshi、Fujimoto Yuki、Sasada Tetsuro、Kohashi Kenichi、Bando Hideaki、Endo Itaru、Nakatsura Tetsuya
- Journal Title
  
  Cancer Science
  
  Volume: 110 Issue: 10 Pages: 3049-3060
- DOI
  10.1111/cas.14165
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09297, KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-17K08722, KAKENHI-PROJECT-18K19490
[Journal Article] がん免疫療法のバイオマーカーの現状および今後の展望.2019
- Author(s)
  松尾規和，笹田哲朗
- Journal Title
  
  実験医学増刊「がん免疫療法の個別化を支える新・腫瘍免疫学」
  
  Volume: 37 Pages: 180-188
- Data Source
  KAKENHI-PROJECT-17H04278
[Journal Article] Immunological consequences following splenectomy in patients with liver cirrhosis.2019
- Author(s)
  Hirakawa Y, Ogata T, Sasada T, Yamashita T, Itoh K, Tanaka H, Okuda K.
- Journal Title
  
  Exp Ther Med.
  
  Volume: 18 Pages: 848-856
- DOI
  10.3892/etm.2019.7640
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-18K19490
[Journal Article] Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations2019
- Author(s)
  Iiizumi Susumu、Ohtake Junya、Murakami Naoko、Kouro Taku、Kawahara Mamoru、Isoda Fumiko、Hamana Hiroshi、Kishi Hiroyuki、Nakamura Norihiro、Sasada Tetsuro
- Journal Title
  
  Cancers
  
  Volume: 11 Issue: 2 Pages: 266-266
- DOI
  10.3390/cancers11020266
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K19441, KAKENHI-PROJECT-18K19490, KAKENHI-PLANNED-16H06499, KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-18K07260, KAKENHI-PROJECT-16H06277
[Journal Article] 遺伝子変異由来ネオアンチゲンを標的とした特異的免疫療法.2019
- Author(s)
  紅露拓，笹田哲朗
- Journal Title
  
  医学のあゆみ
  
  Volume: 271 Pages: 163-168
- Data Source
  KAKENHI-PROJECT-18K19490
[Journal Article] 遺伝子変異由来ネオアンチゲンを標的とした特異的免疫療法.2019
- Author(s)
  紅露拓，笹田哲朗
- Journal Title
  
  医学のあゆみ
  
  Volume: 271 Pages: 163-168
- Data Source
  KAKENHI-PROJECT-17H04278
[Journal Article] がんワクチン療法の将来2018
- Author(s)
  飯泉　晋, 中村徳弘, 笹田哲朗.
- Journal Title
  
  腫瘍内科
  
  Volume: 22 Pages: 135-141
- Data Source
  KAKENHI-PROJECT-17H04278
[Journal Article] Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment.2018
- Author(s)
  Ono T, Azuma K, Kawahara A, Sasada T, Matsuo N, Kakuma T, Kamimura H, Maeda R, Hattori C, On K, Nagata K, Sato F, Chitose SI, Shin B, Aso T, Akiba J, Umeno H.
- Journal Title
  
  Head Neck.
  
  Volume: 40 Issue: 9 Pages: 2007-2019
- DOI
  10.1002/hed.25189
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17H04278
[Journal Article] がんワクチン療法の将来2018
- Author(s)
  飯泉　晋, 中村徳弘, 笹田哲朗.
- Journal Title
  
  腫瘍内科
  
  Volume: 22 Pages: 135-141
- Data Source
  KAKENHI-PROJECT-18K19490
[Journal Article] Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer.2018
- Author(s)
  Tsukagoshi M, Wada S, Hirono S, Yoshida S, Yada E, Sasada T, Shirabe K, Kuwano H, Yamaue H.
- Journal Title
  
  Oncotarget.
  
  Volume: 9 Issue: 59 Pages: 31448-31458
- DOI
  10.18632/oncotarget.25837
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K19490, KAKENHI-PROJECT-17H01580, KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-16K15623, KAKENHI-PROJECT-16H06277
[Journal Article] Enhanced expression of PD-L1 in non-muscle-invasive bladder cancer after treatment with Bacillus Calmette-Guerin.2018
- Author(s)
  Hashizume A, Umemoto S, Yokose T, Nakamura Y, Yoshihara M, Shoji K, Wada S, Miyagi Y, Kishida T, Sasada T.
- Journal Title
  
  Oncotarget.
  
  Volume: 9 Issue: 75 Pages: 34066-34078
- DOI
  10.18632/oncotarget.26122
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K19490, KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-16H06277
[Journal Article] A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma.2018
- Author(s)
  Narita Y, Arakawa Y, Yamasaki F, Nishikawa R, Aoki T, Kanamori M, Nagane M, Kumabe T, Hirose Y, Ichikawa T, Kobayashi H, Fujimaki T, Goto H, Takeshima H, Ueba T, Abe H, Tamiya T, Sonoda Y, Natsume A, Kakuma T, Sugita Y, Komatsu N, Yamada A, Sasada T, Matsueda S, Shichijo S, Itoh K, Terasaki M.
- Journal Title
  
  Neuro Oncol.
  
  Volume: 21 Issue: 3 Pages: 348-359
- DOI
  10.1093/neuonc/noy200
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K10867, KAKENHI-PROJECT-18K19490, KAKENHI-PLANNED-17H06356, KAKENHI-PROJECT-16H05436, KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-16K10754, KAKENHI-PROJECT-16K10757, KAKENHI-PROJECT-18K09004
[Journal Article] Immuno-Oncologyにおけるトランスレーショナルリサーチ：大腸癌手術検体の網羅的解析による各種免疫細胞の形質・機能の解析2018
- Author(s)
  大竹淳矢, 風間慶祐, 塩澤学, 笹田哲朗.
- Journal Title
  
  癌と化学療法
  
  Volume: 45 Pages: 1238-1241
- Data Source
  KAKENHI-PROJECT-17H04278
[Journal Article] Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11+ or -A33+ allele.2017
- Author(s)
  Sakamoto S, Matsueda S, Takamori S, Toh U, Noguchi M, Yutani S, Yamada A, Shichijo S, Yamada T, Suekane S, Kawano K, Naitou M, Sasada T, Hattori N, Kohno N, Itoh K.
- Journal Title
  
  Cancer Sci.
  
  Volume: 印刷中 Issue: 4 Pages: 598-603
- DOI
  10.1111/cas.13189
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-16K15601, KAKENHI-PROJECT-17K07229, KAKENHI-PROJECT-15H04831
[Journal Article] Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer.2017
- Author(s)
  Sakamoto S, Yamada T, Terazaki Y, Yoshiyama K, Sugawara S, Takamori S, Matsueda S, Shichijo S, Yamada A, Noguchi M, Itoh K, Hattori N, Kohno N, Sasada T.
- Journal Title
  
  Clin Lung Cancer.
  
  Volume: 印刷中 Issue: 6 Pages: e385-e394
- DOI
  10.1016/j.cllc.2017.03.011
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-16K15601, KAKENHI-PROJECT-17K07229, KAKENHI-PROJECT-15H04831
[Journal Article] Use of patient-derived xenograft mouse models in cancer research and treatment.2017
- Author(s)
  Yada E, Wada S, Yoshida S, Sasada T.
- Journal Title
  
  Future Sci OA.
  
  Volume: 4 Issue: 3
- DOI
  10.4155/fsoa-2017-0136
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-16K15601
[Journal Article] Are peptide vaccines viable in combination with other cancer immunotherapies?2017
- Author(s)
  Ohtake J, Sasada T.
- Journal Title
  
  Future Oncol.
  
  Volume: 13 Issue: 18 Pages: 1577-1580
- DOI
  10.2217/fon-2017-0136
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-16K15601
[Journal Article] ネオアンチゲンを標的とした免疫療法2017
- Author(s)
  笹田哲朗
- Journal Title
  
  医学のあゆみ　がん免疫療法の躍進
  
  Volume: 263 (1) Pages: 13-19
- Data Source
  KAKENHI-PROJECT-17H04278
[Journal Article] Programmed cell death-ligand 1 expression and immunoscore in stage II and III non-small cell lung cancer patients receiving adjuvant chemotherapy.2017
- Author(s)
  Ishii H, Azuma K, Kawahara A, Matsuo N, Tokito T, Kinoshita T, Yamada K, Sasada T, Akiba J, Hoshino T.
- Journal Title
  
  Oncotarget.
  
  Volume: 8 Issue: 37 Pages: 61618-61625
- DOI
  10.18632/oncotarget.18651
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K15601
[Journal Article] A randomized phase II trial of personalized peptide vaccine with low dose cyclophosphamide in biliary tract cancer.2017
- Author(s)
  Shirahama T, Muroya D, Matsueda S, Yamada A, Shichijo S, Naito M, Yamashita T, Sakamoto S, Okuda K, Itoh K, Sasada T, Yutani S.
- Journal Title
  
  Cancer Sci.
  
  Volume: 印刷中 Issue: 5 Pages: 838-845
- DOI
  10.1111/cas.13193
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-16K15601, KAKENHI-PROJECT-17K07229
[Journal Article] Association between PD-L1 expression combined with tumor-infiltrating lymphocytes and the prognosis of patients with advanced hypopharyngeal squamous cell carcinoma.2017
- Author(s)
  Ono T, Azuma K, Kawahara A, Sasada T, Hattori S, Sato F, Shin B, Chitose SI, Akiba J, Hirohito U.
- Journal Title
  
  Oncotarget.
  
  Volume: 8 Issue: 54 Pages: 92699-92714
- DOI
  10.18632/oncotarget.21564
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-16K15601
[Journal Article] 遺伝子変異新規抗原（ネオアンチゲン）を標的としたがん免疫療法2017
- Author(s)
  笹田哲朗
- Journal Title
  
  日本臨床（特集）がん免疫療法
  
  Volume: 75 (2) Pages: 189-195
- Data Source
  KAKENHI-PROJECT-16K15601
[Journal Article] 遺伝子変異新規抗原（ネオアンチゲン）を標的としたがん免疫療法2017
- Author(s)
  笹田哲朗
- Journal Title
  
  日本臨床　（特集）がん免疫療法
  
  Volume: 75 (2) Pages: 189-195
- Data Source
  KAKENHI-PROJECT-26293293
[Journal Article] Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinoma.2017
- Author(s)
  Suekane S, Ueda K, Nishihara K, Sasada T, Yamashita T, Koga N, Yutani S, Shichijo S, Itoh K, Igawa T, Noguchi M.
- Journal Title
  
  Cancer Sci.
  
  Volume: 108 Issue: 12 Pages: 2430-2437
- DOI
  10.1111/cas.13404
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-15K10614, KAKENHI-PROJECT-16K15601
[Journal Article] ネオアンチゲンを標的とした免疫療法2017
- Author(s)
  笹田哲朗
- Journal Title
  
  医学のあゆみ　がん免疫療法の躍進
  
  Volume: 263 (1) Pages: 13-19
- Data Source
  KAKENHI-PROJECT-16K15601
[Journal Article] Enhancement of humoral and cell mediated immune response to HPV16 L1-derived peptides subsequent to vaccination with prophylactic bivalent HPV L1 virus-like particle vaccine in healthy females.2017
- Author(s)
  Yokomine M, Matsueda S, Kawano K, Sasada T, Fukui A, Yamashita T, Komatsu N, Shichijo S, Tasaki K, Matsukuma K, Itoh K, Kamura T, Ushijima K.
- Journal Title
  
  Exp Ther Med.
  
  Volume: 13 Issue: 4 Pages: 1500-1505
- DOI
  10.3892/etm.2017.4150
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-16K15601
[Journal Article] Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies2017
- Author(s)
  Yutani Shigeru、Shirahama Takahisa、Muroya Daisuke、Matsueda Satoko、Yamaguchi Rin、Morita Michi、Shichijo Shigeki、Yamada Akira、Sasada Tetsuro、Itoh Kyogo
- Journal Title
  
  Cancer Science
  
  Volume: 108 Issue: 9 Pages: 1732-1738
- DOI
  10.1111/cas.13301
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K07229, KAKENHI-PROJECT-16K15601
[Journal Article] Immune Responses to Epidermal Growth Factor Receptor (EGFR) and Their Application for Cancer Treatment.2016
- Author(s)
  Sasada T, Azuma K, Ohtake J, Fujimoto Y.
- Journal Title
  
  Front Pharmacol.
  
  Volume: 7 Pages: 405-405
- DOI
  10.3389/fphar.2016.00405
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-16K15601
[Journal Article] がんワクチン療法の進歩2016
- Author(s)
  笹田哲朗
- Journal Title
  
  Pharma Media　（特集）がん免疫療法ー最近の進歩と展望
  
  Volume: 34 (10) Pages: 17-22
- Data Source
  KAKENHI-PROJECT-16K15601
[Journal Article] A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer.2016
- Author(s)
  Noguchi M, Moriya F, Koga N, Matsueda S, Sasada T, Yamada A, Kakuma T, Itoh K.
- Journal Title
  
  Cancer Immunol Immunother.
  
  Volume: 65 Issue: 2 Pages: 151-60
- DOI
  10.1007/s00262-015-1781-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] 遺伝子変異を標的としたがん免疫療法2016
- Author(s)
  笹田哲朗、大竹淳矢、内山秀美、和田聡、矢田英理香、藤本佑希、吉田慎太郎
- Journal Title
  
  BIO Clinica
  
  Volume: 31 Pages: 102-106
- Data Source
  KAKENHI-PROJECT-26293293
[Journal Article] n Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy.2016
- Author(s)
  Noguchi M, Matsumoto K, Uemura H, Arai G, Eto M, Naito S, Ohyama C, Nasu Y, Tanaka M, Moriya F, Suekane S, Matsueda S, Komatsu N, Sasada T, Yamada A, Kakuma T, Itoh K.
- Journal Title
  
  Clin Cancer Res
  
  Volume: 22 Issue: 1 Pages: 54-60
- DOI
  10.1158/1078-0432.ccr-15-1265
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26293353
[Journal Article] Prospect and progress of personalized peptide vaccinations for advanced cancers.2016
- Author(s)
  Sakamoto S, Noguchi M, Yamada A, Itoh K, Sasada T.
- Journal Title
  
  Expert Opin Biol Ther.
  
  Volume: 16 Issue: 5 Pages: 689-98
- DOI
  10.1517/14712598.2016.1161752
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26293293
[Journal Article] Current status and future prospects of peptide-based cancer vaccines.2016
- Author(s)
  Wada S, Yada E, Ohtake J, Fujimoto Y, Uchiyama H, Yoshida S, Sasada T.
- Journal Title
  
  Immunotherapy.
  
  Volume: 8 Issue: 11 Pages: 1321-1333
- DOI
  10.2217/imt-2016-0063
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-16K15601
[Journal Article] Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer.2016
- Author(s)
  Takayama K, Sugawara S, Saijo Y, Maemondo M, Sato A, Takamori S, Harada T, Sasada T, Kakuma T, Kishimoto J, Yamada A, Noguchi M, Itoh K, Nakanishi Y.
- Journal Title
  
  J Immunol Res.
  
  Volume: 2016 Pages: 1745108-1745108
- DOI
  10.1155/2016/1745108
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-15K15320, KAKENHI-PROJECT-16K15601
[Journal Article] がんワクチン療法の進歩2016
- Author(s)
  笹田哲朗
- Journal Title
  
  Pharma Media　（特集）がん免疫療法ー最近の進歩と展望
  
  Volume: 34 (10) Pages: 17-22
- Data Source
  KAKENHI-PROJECT-26293293
[Journal Article] Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients.2016
- Author(s)
  Iwasa S, Yamada Y, Heike Y, Shoji H, Honma Y, Komatsu N, Matsueda S, Yamada A, Morita M, Yamaguchi R, Tanaka N, Kawahara A, Kage M, Shichijo S, Sasada T, Itoh K.
- Journal Title
  
  Cancer Sci.
  
  Volume: 印刷中 Issue: 5 Pages: 590-600
- DOI
  10.1111/cas.12919
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-16K19381
[Journal Article] Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients.2015
- Author(s)
  Yutani S, Ueshima K, Abe K, Ishiguro A, Eguchi J, Matsueda S, Komatsu N, Shichijo S, Yamada A, Itoh K, Sasada T, Kudo M, Noguchi M.
- Journal Title
  
  J Immunol Res.
  
  Volume: 2015 Pages: 473909-473909
- DOI
  10.1155/2015/473909
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Haptoglobin promoter polymorphism rs5472 as a prognostic biomarker for peptide vaccine efficacy in castration-resistant prostate cancer patients.2015
- Author(s)
  Araki H, Pang X, Komatsu N, Soejima M, Miyata N, Takaki M, Muta S, Sasada T, Noguchi M, Koda Y, Itoh K, Kuhara S, Tashiro K.
- Journal Title
  
  Cancer Immunol Immunother.
  
  Volume: 64 Issue: 12 Pages: 1565-1573
- DOI
  10.1007/s00262-015-1756-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26460894, KAKENHI-PROJECT-25460881, KAKENHI-PROJECT-26293293
[Journal Article] Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination.2015
- Author(s)
  Sakamoto S, Yoshitomi M, Yutani S, Terazaki Y, Yoshiyama K, Ioji T, Matsueda S, Yamada A, Takamori S, Itoh K, Hattori N, Kohno N, Sasada T.
- Journal Title
  
  Hum Vaccin Immunother.
  
  Volume: 11 Issue: 12 Pages: 2784-9
- DOI
  10.1080/21645515.2015.1075107
- NAID
  120006799351
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens.2015
- Author(s)
  Yamada T, Terazaki Y, Sakamoto S, Yoshiyama K, Matsueda S, Komatsu N, Waki K, Yamada A, Kawahara A, Kage M, Sugawara S, Yamashita Y, Sasada T, Takamori S, Itoh K.
- Journal Title
  
  Int J Oncol.
  
  Volume: 46 Issue: 1 Pages: 55-62
- DOI
  10.3892/ijo.2014.2699
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Personalized Peptide Vaccination for Advanced Colorectal Cancer.2015
- Author(s)
  Sasada T, Kibe S, Akagi Y, Itoh K.
- Journal Title
  
  OncoImmunology.
  
  Volume: 印刷中 Issue: 5 Pages: e1005512-e1005512
- DOI
  10.1080/2162402x.2015.1005512
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293
[Journal Article] Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele.2015
- Author(s)
  Sakamoto S, Matsueda S, Takamori S, Toh U, Noguchi M, Yutani S, Yamada A, Shichijo S, Yamada T, Suekane S, Kawano K, Sasada T, Hattori N, Kohno N, Itoh K.
- Journal Title
  
  Cancer Sci.
  
  Volume: 106 Issue: 10 Pages: 1257-1263
- DOI
  10.1111/cas.12757
- NAID
  120006799352
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26461965, KAKENHI-PROJECT-15H04831, KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castrate-resistant prostate cancer: dose-related immune boosting and suppression.2015
- Author(s)
  Noguchi M, Arai G, Matsumoto K, Naito S, Moriya F, Suekane S, Komatsu N, Matsueda S, Sasada T, Yamada A, Itoh K.
- Journal Title
  
  Cancer Immunol Immunother.
  
  Volume: 64 Issue: 4 Pages: 493-505
- DOI
  10.1007/s00262-015-1660-1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592408, KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Feasibility study of personalized peptide vaccination for recurrent ovarian cancer patients2014
- Author(s)
  Kawano K, Tsuda N, Matsueda S, Sasada T, Watanabe N, Ushijima K, Yamaguchi T, Yokomine M, Itoh K, Yamada A, Kamura T.
- Journal Title
  
  Immunopharmacol Immunotoxicol
  
  Volume: (in press)
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] Humoral immune responses to EGFR-derived peptides predict progression-free and overall survival of non-small cell lung cancer patients receiving gefitinib.2014
- Author(s)
  Azuma K, Komatsu N, Hattori S, Matsueda S, Kawahara A, Sasada T, Itoh K, Hoshino T.
- Journal Title
  
  PLoS One.
  
  Volume: 9 Issue: 1 Pages: e86667-e86667
- DOI
  10.1371/journal.pone.0086667
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913, KAKENHI-PROJECT-26460462
[Journal Article] Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients.2014
- Author(s)
  Takahashi R, Toh U, Iwakuma N, Takenaka M, Otsuka H, Furukawa M, Fujii T, Seki N, Kawahara A, Kage M, Matsueda S, Akagi Y, Yamada A, Itoh K, Sasada T.
- Journal Title
  
  Breast Cancer Res.
  
  Volume: 16 Issue: 4 Pages: 00-00
- DOI
  10.1186/bcr3685
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23591914, KAKENHI-PROJECT-24591925, KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-26461965
[Journal Article] Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer.2014
- Author(s)
  Kibe S, Yutani S, Motoyama S, Nomura T, Tanaka N, Kawahara A, Yamaguchi T, Matsueda S, Komatsu N, Miura M, Hinai Y, Hattori S, Yamada A, Kage M, Itoh K, Akagi Y, Sasada T.
- Journal Title
  
  Cancer Immunol Res.
  
  Volume: 2 Issue: 12 Pages: 1154-1162
- DOI
  10.1158/2326-6066.cir-14-0035
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Feasibility study of personalized peptide vaccination for recurrent ovarian cancer patients.2014
- Author(s)
  Kawano K, Tsuda N, Matsueda S, Sasada T, Watanabe N, Ushijima K, Yamaguchi T, Yokomine M, Itoh K, Yamada A, Kamura T.
- Journal Title
  
  Immunopharmacol Immunotoxicol.
  
  Volume: 36 Issue: 3 Pages: 224-236
- DOI
  10.3109/08923973.2014.913617
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23591913, KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] Personalized Peptide Vaccine for Treatment of Advanced Cancer.2014
- Author(s)
  Sasada T, Yamada A, Noguchi M, Itoh K.
- Journal Title
  
  Curr Med Chem.
  
  Volume: 21 Issue: 21 Pages: 2332-2345
- DOI
  10.2174/0929867321666140205132936
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913, KAKENHI-PROJECT-26293293
[Journal Article] Personalized peptide vaccine for treatment of advanced cancer2014
- Author(s)
  Sasada T, Yamada A, Noguchi M, Itoh K.
- Journal Title
  
  Curr Med Chem.
  
  Volume: (Epub ahead of print)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine.2013
- Author(s)
  Noguchi M, Sasada T, Itoh K.
- Journal Title
  
  Cancer Immunol Immunother.
  
  Volume: 62 Issue: 5 Pages: 919-29
- DOI
  10.1007/s00262-012-1379-1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] Personalized peptide vaccination : a new approach for advanced cancer as therapeutic cancer vaccine2013
- Author(s)
  Noguchi M, Sasada T, Itoh K.
- Journal Title
  
  Cancer Immunol Immunother
  
  Volume: 62 Pages: 919-29
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients2013
- Author(s)
  Takahashi R, Ishibashi Y, Hiraoka K, Matsueda S, Kawano K, Kawahara A, Kage M, Ohshima K, Yamanaka R, Shichijo S, Shirouzu K, Itoh K, Sasada T.
- Journal Title
  
  Cancer Sci.
  
  Volume: 104(10) Pages: 1285-94
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients : Prolongation of prostate-specific antigen doubling time.2013
- Author(s)
  Noguchi M, Moriya F, Suekane S, Ohnishi R, Matsueda S, Sasada T, Yamada A, Itoh K.
- Journal Title
  
  BMC Cancer
  
  Volume: 13 Issue: 1 Pages: 613-613
- DOI
  10.1186/1471-2407-13-613
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913
[Journal Article] A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients2013
- Author(s)
  Yutani S, Komatsu N, Yoshitomi M, Matsueda S, Yonemoto K, Mine T, Noguchi M, Ishihara Y, Yamada A, Itoh K, Sasada T.
- Journal Title
  
  Oncol Rep.
  
  Volume: 30(3) Pages: 1094-100
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients.2013
- Author(s)
  Takahashi R, Ishibashi Y, Hiraoka K, Matsueda S, Kawano K, Kawahara A, Kage M, Ohshima K, Yamanaka R, Shichijo S, Shirouzu K, Itoh K, Sasada T.
- Journal Title
  
  Cancer Sci.
  
  Volume: 104 Issue: 10 Pages: 1285-1294
- DOI
  10.1111/cas.12226
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913, KAKENHI-PROJECT-23659695, KAKENHI-PROJECT-23790425, KAKENHI-PROJECT-24390347
[Journal Article] Current status of immunotherapy for the treatment of biliary tract cancer2013
- Author(s)
  Takahashi R, Yoshitomi M, Yutani S, Shirahama T, Noguchi M, Yamada A, Itoh K, Sasada T.
- Journal Title
  
  Hum Vaccin Immunother
  
  Volume: 9(5) Pages: 1069-1072
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] Humoral immune responses to CTL epitope peptides from tumor-associated antigens are widely detectable in humans: a new biomarker for overall survival of patients with malignant diseases.2013
- Author(s)
  Matsueda S, Komatsu N, Kusumoto K, Koga S, Yamada A, Kuromatsu R, Yamada S, Seki R, Yutani S, Shichijo S, Mine T, Fukuda T, Okamura T, Okuda S, Sata M, Honda J, Kaji M, Itoh K, Sasada T.
- Journal Title
  
  Dev Comp Immunol.
  
  Volume: 41(1) Issue: 1 Pages: 68-76
- DOI
  10.1016/j.dci.2013.04.004
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913, KAKENHI-PROJECT-24791452
[Journal Article] The next generation of peptide vaccines for advanced cancer2013
- Author(s)
  Yamada A, Sasada T, Noguchi M, Itoh K .
- Journal Title
  
  Cancer Sci.
  
  Volume: 104(1) Pages: 15-21
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] A Phase II study of personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients2013
- Author(s)
  Yutani S., Komatsu N., Yoshitomi M., 他8名
- Journal Title
  
  Oncology Report
  
  Volume: 30 Issue: 3 Pages: 1094-1100
- DOI
  10.3892/or.2013.2556
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22700297, KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913
[Journal Article] Next generation peptide vaccines for advanced cancer.2013
- Author(s)
  Yamada A, Sasada T, Noguchi M, Itoh K.
- Journal Title
  
  Cancer Sci
  
  Volume: 104(1) Issue: 1 Pages: 15-21
- DOI
  10.1111/cas.12050
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913
[Journal Article] テーラーメイドがんペプチドワクチン療法2013
- Author(s)
  笹田哲朗
- Journal Title
  
  ライフライン21 がんの先進医療
  
  Volume: 11 Pages: 45-48
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] Haptoglobin proved a prognostic biomarker in peripheral blood of patients with personalized Peptide vaccinations for advanced castration-resistant prostate cancer.2013
- Author(s)
  Pang X, Tashiro K, Eguchi R, Komatsu N, Sasada T, Itoh K, Kuhara S.
- Journal Title
  
  Biosci Biotechnol Biochem.
  
  Volume: 77 Pages: 766-70
- NAID
  10031170716
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] EGFR T790M Mutation as a Possible Target for Immunotherapy; Identification of HLA-A*0201-Restricted T Cell Epitopes Derived from the EGFR T790M Mutation2013
- Author(s)
  Yamada T
- Journal Title
  
  PLOS ONE
  
  Volume: 8 Issue: 11 Pages: e78389-e78389
- DOI
  10.1371/journal.pone.0078389
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590098, KAKENHI-PROJECT-23591913
[Journal Article] Current status of immunotherapy for the treatment of biliary tract cancer.2013
- Author(s)
  Takahashi R, Yoshitomi M, Yutani S, Shirahama T, Noguchi M, Yamada A, Itoh K, Sasada T.
- Journal Title
  
  Hum Vaccin Immunother.
  
  Volume: 9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine.2013
- Author(s)
  Yutani S, Komatsu N, Matsueda S, Yoshitomi M, Shirahama T, Yamada A, Itoh K, Sasada T.
- Journal Title
  
  Evid Based Complement Alternat Med.
  
  Volume: 2013 Pages: 981717-981717
- DOI
  10.1155/2013/981717
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913, KAKENHI-PROJECT-24791452
[Journal Article] Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination2012
- Author(s)
  Komatsu N, Noguchi M, et al
- Journal Title
  
  Cancer
  
  Volume: (In press) Issue: 12 Pages: 3208-3221
- DOI
  10.1002/cncr.26636
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591782, KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913
[Journal Article] Personalized peptide vaccination for advanced biliary tract cancer: IL-6, nutritional status, and pre-existing antigen-specific immunity as possible biomarkers for patient prognosis.2012
- Author(s)
  Yoshitomi M, Yutani S, Matsueda S, Ioji T, Komatsu N, Shichijo S, Yamada A, Itoh K, Sasada T, Kinoshita H.
- Journal Title
  
  Exp Ther Med
  
  Volume: 3 Issue: 3 Pages: 463-469
- DOI
  10.3892/etm.2011.424
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] Identification of B cell epitopes reactive to human papillomavirus type-16 L1- derived peptides.2012
- Author(s)
  Fukui A, Matsueda S, Kawano K, Tsuda N, Komatsu N, Shichijo S, Sasada T, Hattori S, Ushijima K, Itoh K, Kamura T.
- Journal Title
  
  Virol J.
  
  Volume: 9 Issue: 1 Pages: 199-199
- DOI
  10.1186/1743-422x-9-199
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] Personalized peptide vaccination in patients with refractory non-small cell lung cancer2012
- Author(s)
  Yoshiyama K, Terazaki Y, Satoko Matsueda S, Shichijo S, Noguchi M, Yamada A, Mine T, Ioji T, Itoh K, Shirouzu K, Sasada T, Takamori S.
- Journal Title
  
  Int J Oncol
  
  Volume: 40 Pages: 1492-500
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] Personalized peptide vaccination in patients with refractory non-small　cell lung cancer.2012
- Author(s)
  Yoshiyama K, Terazaki Y, Satoko Matsueda S, Shichijo S, Noguchi M, Yamada A, Mine T, Ioji T, Itoh K, Shirouzu K, Sasada T and Takamori S.
- Journal Title
  
  Int J Oncol
  
  Volume: 40 Pages: 1492-1500
- DOI
  10.3892/ijo.2012.1351
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913
[Journal Article] Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination2012
- Author(s)
  Komatsu K, Matsueda S, Tashiro K, Ioji T, Shichijo S, Noguchi M, Yamada A, Doi A, Suekane S, Moriya F, Matsuoka K, Kuhara S, Itoh K, Sasada T.
- Journal Title
  
  Cancer
  
  Volume: 118(12) Pages: 3208-21
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] Personalized peptide vaccination : a novel immunotherapeutic approach for advanced cancer2012
- Author(s)
  Sasada T, Noguchi M, Yamada A, Itoh K.
- Journal Title
  
  Hum Vaccin Immunother
  
  Volume: 8(9) Pages: 1309-1313
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy.2012
- Author(s)
  Zaizen Y, Azuma K, Kurata S, Sadashima E, Hattori S, Sasada T, Imamura Y, Kaida H, Kawahara A, Kinoshita T, Ishibashi M, Hoshino T.
- Journal Title
  
  Eur J Radiol.
  
  Volume: 81 Issue: 12 Pages: 4179-84
- DOI
  10.1016/j.ejrad.2012.07.009
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913, KAKENHI-PROJECT-23790425
[Journal Article] Phase II study of personalized peptide vaccination in patients with castration-resistant prostate cancer evaluating progression status with or without prior docetaxel-based chemotherapy2012
- Author(s)
  Noguchi M, Moriya F, Suekane S, Arai G, Yoshihara K, Ioji T, Matsueda S, Sasada T, Yamada A, Itoh K.
- Journal Title
  
  Prostate
  
  Volume: 72(8) Pages: 834-45
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] Personalized peptide vaccination: A novel immunotherapeutic approach for advanced cancer.2012
- Author(s)
  Sasada T, Noguchi M, et al.
- Journal Title
  
  Hum Vaccin Immunother
  
  Volume: 8 Issue: 9 Pages: 1309-1313
- DOI
  10.4161/hv.20988
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591782, KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913
[Journal Article] Personalized peptide vaccination for advanced biliary tract cancer : IL-6, nutritional status, and pre-existing antigen-specific immunity as possible biomarkers for patient prognosis2012
- Author(s)
  Yoshitomi M, Yutani S, Matsueda S, Ioji T, Komatsu N, Shichijo S, Yamada A, Itoh K, Sasada T, Kinoshita H.
- Journal Title
  
  Exp Ther Med.
  
  Volume: 3(3) Pages: 463-469
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] Immunological Evaluation of Personalized Peptide Vaccination in Refractory Small Cell Lung Cancer2012
- Author(s)
  Terazaki Y, Yoshiyama K, Matsueda S, Watanabe N, Kawahara A, Naito Y, Suekane S, Komatsu N, Ioji T, Yamada A, Mine T, Terasaki M, Itoh K, Takamori S, Sasada T.
- Journal Title
  
  Cancer Sci.
  
  Volume: 103(4) Pages: 638-44
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancer.2012
- Author(s)
  Terazaki Y, Yoshiyama K, Matsueda S, Watanabe N, Yamada A, Mine T, Terasaki M, Itoh K, Takamori S, Sasada T.
- Journal Title
  
  Cancer Sci
  
  Volume: 103(4) Issue: 4 Pages: 638-644
- DOI
  10.1111/j.1349-7006.2012.02202.x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913, KAKENHI-PROJECT-23790425
[Journal Article] Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance.2011
- Author(s)
  Sasada T, Suekane S.
- Journal Title
  
  Immunotherapy
  
  Volume: 3 Pages: 1235-51
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination2011
- Author(s)
  Noguchi M, Mine T, Komatsu N, Suekane S, Moriya F, Matsuoka K, Yutani Y, Shichijo S, Yamada A, Toh U, Kawano K, Azuma K, Uemura H, Okuno K, Matsumoto K, Yanagimoto H, Yamanaka R, Oka M, Todo S, Sasada T, Itoh K.
- Journal Title
  
  Cancer Biol Ther.
  
  Volume: 10 Pages: 1266-79
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy2011
- Author(s)
  Noguchi M, et al
- Journal Title
  
  Prostate
  
  Volume: 71 Issue: 8 Pages: 470-479
- DOI
  10.1002/pros.21485
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591782, KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913
[Journal Article] がん免疫療法―最近のトピックと今後の展望―2011
- Author(s)
  笹田哲朗
- Journal Title
  
  久留米医学会雑誌
  
  Volume: 74 Pages: 221-228
- Data Source
  KAKENHI-PROJECT-23591913
[Journal Article] The TCR Cβ FG Loop Regulates αβ T Cell Development.2006
- Author(s)
  Touma M, Sasada T, et al.
- Journal Title
  
  Journal of Immunology (In press)
- Data Source
  KAKENHI-PROJECT-17591452
[Journal Article] Immediate early response gene X-1, a stress-inducible antiapoptotic gene, encodes CTL epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in gastric cancer patients.2004
- Author(s)
  Sasada T
- Journal Title
  
  Cancer Resserch 64
  
  Pages: 2882-2888
- Data Source
  KAKENHI-PROJECT-15591461
[Journal Article] Re : The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators.2004
- Author(s)
  Sasada T, Takabayashi A.
- Journal Title
  
  Surgery. 136
  
  Pages: 1101-1101
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15591461
[Journal Article] Re : The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators.2004
- Author(s)
  Sasada T
- Journal Title
  
  Surgery 136
  
  Pages: 1101-1101
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591461
[Journal Article] Usefulness of 99 mTc-sestamibi scintigraphy in suggesting the therapeutic effect of chemotherapy against gastric cancer.2004
- Author(s)
  Kawata K, Kanai M, Sasada T, Iwata S, Yamamoto N, Takabayashi A.
- Journal Title
  
  Clin Cancer Res. 10
  
  Pages: 3788-3793
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15591461
[Journal Article] Immediate early response gene X-1, a stress-inducible antiapoptotic gene, encodes CTL epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in gastric cancer patients.2004
- Author(s)
  Sasada T
- Journal Title
  
  Cancer Research 64
  
  Pages: 2882-2888
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591461
[Journal Article] Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients.2004
- Author(s)
  Azuma K, Sasada T, Takedatsu H, Shomura H, Koga M, Maeda Y, Yao A, Hirai T, Takabayashi A, Shichijo S, Itoh K.
- Journal Title
  
  Clin Cancer Res. 10
  
  Pages: 6695-6702
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15591461
[Journal Article] Immediate early response gene X-1, a stress-inducible antiapoptotic gene, encodes cytotoxic T-lymphocyte (CTL) epitopes capable of inducing human leukocyte antigen-A33-restricted and tumor-reactive CTLs in gastric cancer patients.2004
- Author(s)
  Sasada T, Takedatsu H, Azuma K, Koga M, Maeda Y, Shichijo S, Shoumura H, Hirai T, Takabayashi A, Itoh K.
- Journal Title
  
  Cancer Res. 64
  
  Pages: 2882-2888
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15591461
[Journal Article] Re : The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune nechanisms, and their association with prognostic indicators.2004
- Author(s)
  Sasada T
- Journal Title
  
  Surgery 136
  
  Pages: 1101-1101
- Data Source
  KAKENHI-PROJECT-15591461
[Journal Article] CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies : possible involvement of regulatory T cells in disease progression.2003
- Author(s)
  Sasada T, Kimura M, Yoshida Y, Kanai M, Takabayashi A.
- Journal Title
  
  Cancer. 98
  
  Pages: 1089-1099
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15591461
[Journal Article] Change in mitochondrial membrane potential in peripheral blood lymphocytes, especially in natural killer cells, is a possible marker for surgical stress on the immune system.2003
- Author(s)
  Takabayashi A, Kanai M, Kawai Y, Iwata S, Sasada T, Obama K, Taki Y.
- Journal Title
  
  World J Surg. 27
  
  Pages: 659-665
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15591461
[Journal Article] CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies : possible involvement of regulatory T cells in disease progression.2003
- Author(s)
  Sasada T
- Journal Title
  
  Cancer 98
  
  Pages: 1089-1099
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591461
[Patent] 新規ネオアンチゲン及びそれらを用いたがん免疫治療薬2020
- Inventor(s)
  笹田哲朗、大竹淳也、飯泉晋、中村徳弘、磯田扶美子、小高和彦
- Industrial Property Rights Holder
  地方独立行政法人神奈川県立病院機構、ブライトパス・バイオ株式会社
- Industrial Property Rights Type
  特許
- Filing Date
  2020
- Overseas
- Data Source
  KAKENHI-PROJECT-17H04278
[Patent] がん免疫療法の予後予測のためのバイオマーカー2018
- Inventor(s)
  笹田哲朗、東公一、松尾規和、星野友昭
- Industrial Property Rights Holder
  地方独立行政法人神奈川県立病院機構、久留米大学
- Industrial Property Rights Type
  特許
- Filing Date
  2018
- Overseas
- Data Source
  KAKENHI-PROJECT-17H04278
[Patent] がん免疫療法の予後予測のためのバイオマーカー2018
- Inventor(s)
  笹田哲朗、東公一、松尾規和、星野友昭
- Industrial Property Rights Holder
  地方独立行政法人神奈川県立病院機構、久留米大学
- Industrial Property Rights Type
  特許
- Filing Date
  2018
- Overseas
- Data Source
  KAKENHI-PROJECT-18K19490
[Patent] 上皮成長因子受容体のT790M点突然変異配列に由来する抗原ペプチド2013
- Inventor(s)
  笹田哲朗、中面哲也、大藤和也
- Industrial Property Rights Holder
  久留米大学、国立がんセンター
- Industrial Property Rights Type
  特許
- Filing Date
  2013-08-08
- Overseas
- Data Source
  KAKENHI-PROJECT-23591913
[Patent] 上皮成長因子受容体のT790M点突然変異配列に由来する抗原ペプチド2013
- Inventor(s)
  笹田哲朗、中面哲也、大藤和也
- Industrial Property Rights Holder
  久留米大学、国立がんセンター
- Industrial Property Rights Type
  特許
- Filing Date
  2013-08-08
- Overseas
- Data Source
  KAKENHI-PROJECT-23591913
[Patent] 上皮成長因子受容体のT790M点突然変異配列に由対する抗原ペプチド2012
- Inventor(s)
  笹田哲朗
- Industrial Property Rights Holder
  久留米大学、久留米リサーチパーク
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2012-177631
- Filing Date
  2012-08-10
- Data Source
  KAKENHI-PROJECT-23591913
[Patent] 上皮成長因子受容体のT790M点突然変異配列に由来する抗原ペプチド2012
- Inventor(s)
  笹田哲朗
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2012-177631
- Filing Date
  2012-08-10
- Overseas
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] Establishment of Organoids Derived from Renal Cell Cancer for Immunopeptidome Analysis.2023
- Author(s)
  辻嘉代子、中村有子、上田宏生、紅露　拓、魏　菲菲、眞野恭伸、洞口　俊、氷室秀知、星野大輔、川村　猛、笹田哲朗
- Organizer
  第82回　日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-23K18346
[Presentation] 難治性軟部腫瘍を対象とするNY-ESO-1 TCR-T細胞療法及びナノ粒子ワクチン併用・前処置非使用療法の第1相治験．2023
- Author(s)
  石原幹也、西田佳弘、北野滋久、川井章、原田直純、宮原慶裕、服部浩佳、高田弘一、江森誠人、角永茂樹、遠藤誠、松本嘉寛、笹田哲朗、佐藤永一、山田知美、松峯昭彦、永田康浩、渡辺隆、影山愼一、珠玖洋．
- Organizer
  第20回日本臨床腫瘍学会学術集会.
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] 腎がん患者由来オルガノイドの樹立と免疫学的解析の試み2023
- Author(s)
  辻　嘉代子、中村有子、紅露　拓、魏　菲菲、眞野恭伸、洞口　俊、氷室秀知、星野大輔、川村　猛、笹田哲朗
- Organizer
  第27回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] HLA-Mascot: Machine Learning-based False Positive Filter in Tumor Immunopeptidomics by Mass Spectrometry2023
- Author(s)
  魏菲菲，紅露拓，中村有子，上田宏生，氷室秀知，洞口俊，辻嘉代子，眞野恭伸，中村徳弘，川村猛，笹田哲朗
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-22K08724
[Presentation] HLA-Mascot: Machine Learning-based False Positive Filter in Tumor Immunopeptidomics by Mass Spectrometry.2023
- Author(s)
  魏　菲菲，紅露　拓，中村有子，上田宏生，氷室秀知，洞口　俊，辻　嘉代子，眞野恭伸，中村徳弘，川村　猛，笹田哲朗.
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-23K18346
[Presentation] Identification of specific TCR by single-cell analysis of renal cancer-infiltrating T cells and verification of antitumor effect on renal cancer organoids.2023
- Author(s)
  洞口　俊、紅露　拓、氷室秀知、魏　菲菲、眞野恭伸、辻嘉代子、神谷郁也、星野大輔、上原秀一郎、笹田哲朗
- Organizer
  第82回　日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-23K18346
[Presentation] 腎がん浸潤T細胞のシングルセル解析による特異的TCR同定と腎がんオルガノイドに対する抗腫瘍効果の検証2023
- Author(s)
  洞口　俊, 紅露　拓、氷室秀知、魏菲菲、辻嘉代子、神谷郁也、上原秀一郎、笹田哲朗
- Organizer
  第123回日本外科学会学術集会
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] Identification of specific TCR by single-cell analysis of renal cancer-infiltrating T cells and verification of antitumor effect on renal cancer organoids2023
- Author(s)
  洞口　俊、紅露　拓、氷室秀知、魏　菲菲、眞野恭伸、辻嘉代子、神谷郁也、星野大輔、上原秀一郎、笹田哲朗
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] Establishment of Organoids Derived from Renal Cell Cancer for Immunopeptidome Analysis2023
- Author(s)
  辻嘉代子、中村有子、上田宏生、紅露　拓、魏　菲菲、眞野恭伸、洞口　俊、氷室秀知、星野大輔、川村　猛、笹田哲朗
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] HLA-Mascot: Machine Learning-based False Positive Filter in Tumor Immunopeptidomics by Mass Spectrometry2023
- Author(s)
  魏　菲菲，紅露　拓，中村有子，上田宏生，氷室秀知，洞口　俊，辻　嘉代子，眞野恭伸，中村徳弘，川村　猛，笹田哲朗
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] Prognostic factors in the use of immune checkpoint inhibitors for metastatic renal cell carcinoma.2022
- Author(s)
  Nagasaka H, Sasada T, Takebe S, Yamamoto S, Kondo T, Terao H, Nakaigawa N, Kishida T.
- Organizer
  14th European Multidisciplinary Congress on Urological Cancers (EMUC22).
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] 肺腺癌におけるアミノ酸代謝経路に関連する新規予後・免疫治療遺伝子シグネチャーのマルチオミクス解析.2022
- Author(s)
  項慧慧, 笠島理加, 笹田哲朗, 宮城洋平．
- Organizer
  第81回日本癌学会総会.
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] 悪性中皮腫特異的CAR-T細胞の自己活性化シグナル解析.2022
- Author(s)
  紅露拓, 笠島理加, 辻祥太郎, 今井浩三, 笹田哲朗.
- Organizer
  第26回日本がん免疫学会総会.
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] 漢方方剤「通導散」によるアブスコパル効果増強の検討．2022
- Author(s)
  氷室秀知, 若月誠, 東島直子, 紅露拓, 辻嘉代子, 洞口俊, 笹田哲朗．
- Organizer
  第26回日本がん免疫学会総会.
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] 機械学習を用いた末梢血サイトカインに基づくがん免疫治療層別化予測ツールの開発2022
- Author(s)
  魏菲菲, 東公一, 中原善朗, 齋藤春洋, 紅露拓, 氷室秀知, 洞口俊, 辻嘉代子, 笹田哲朗．
- Organizer
  第81回日本癌学会総会.
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] 放射線治療と通導散の併用による抗腫瘍免疫の増強.2022
- Author(s)
  氷室秀知, 紅露拓, 魏菲菲, 洞口俊, 辻嘉代子, 笹田哲朗．
- Organizer
  第81回日本癌学会総会.
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] 漢方製剤「通導散」によるアブスコパル効果増強に関する基礎的検討．2022
- Author(s)
  氷室秀知, 紅露拓, 魏菲菲, 洞口俊, 辻嘉代子, 神谷郁也, 若月誠, 東島直子, 笹田哲朗．
- Organizer
  日本放射線腫瘍学会、第35回学術大会.
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] 個別化がん免疫療法の確立に向けての試み．2022
- Author(s)
  笹田哲朗.
- Organizer
  第26回日本がん免疫学会総会.
- Invited
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] がん免疫療法の現状と展望.2022
- Author(s)
  笹田哲朗.
- Organizer
  第64回日本小児血液・がん学会学術集会.
- Invited
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] MMP3, Fractalkine and MIF are Associated with Clinical Outcomes in Locally Advanced NSCLC Treated with Chemoradiotherapy and Durvalumab.2022
- Author(s)
  Nakahara Y, Saito H, Kouro T, Himuro H, Sasada T, Naoki K.
- Organizer
  IASLC 2022 Asia Conference on Lung Cancer.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] 子宮頸部腺がん三次元スフェロイドにおける炭素線照射の抗腫瘍効果.2022
- Author(s)
  関原和正, 氷室秀知, 齋藤菜緒, 太田幸秀, 笹田哲朗, 星野大輔．
- Organizer
  第81回日本癌学会総会.
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] CAR-T細胞疲弊におけるNFATシグナルの関与.2022
- Author(s)
  紅露拓, 洞口俊, 岸裕幸, 辻祥太郎, 今井浩三, 笹田哲朗．
- Organizer
  第81回日本癌学会総会.
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] A novel prognostic gene signature of amino acid metabolism pathways under lung adenocarcinoma tumor immune microenvironment.2022
- Author(s)
  Xiang H, Kasajima R, Sasada T, Miyagi Y.
- Organizer
  第51回日本免疫学会学術集会.
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] 機械学習を用いた末梢血サイトカインに基づくがん免疫治療層別化予測ツールの開発2022
- Author(s)
  魏菲菲、東公一、中原善朗、齋藤春洋、紅露拓、氷室秀知、洞口俊、辻嘉代子、笹田哲朗
- Organizer
  第81回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-22K08724
[Presentation] Changes of peripheral TCR/BCR repertoire are predictive biomarker for the efficacy of ICI in NSCLC2021
- Author(s)
  Yoshiro Nakahara, Takaji Matsutani, Yuka Igarashi, Norikazu Matsuo, Hidetomo Himuro, Haruhiro Saito, Kouzo Yamada, Kenta Murotani, Tomoaki Hoshino, Koichi Azuma, Tetsuro Sasada
- Organizer
  第80回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] Identification of HLA-binding neoepitopes through peptidome analysis with patient-derived xenografts2021
- Author(s)
  Taku Kouro, Takeshi Kawamura, Hiroki Ueda, Hiroyuki Kishi, Hiroyuki Aburatani, Tetsuro Sasada
- Organizer
  第80回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] 個別化医療のためのネオアンチゲンペプチド同定法2021
- Author(s)
  中村有子、朝比奈佑希、紅露拓、上田宏生、近岡洋子、辰野健二、中村徳弘、油谷浩幸、笹田哲朗、川村猛
- Organizer
  第69回質量分析総合討論会
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] ペプチドミクス解析によるネオアンチゲン同定と特異的T細胞樹立による検証2021
- Author(s)
  紅露拓、朝比奈佑希、中村有子、上田宏生、五十嵐友香、東島直子、近岡洋子、辰野健二、岸裕幸、中村徳弘、油谷浩幸、川村猛、笹田哲朗
- Organizer
  第25回日本がん免疫学会
- Data Source
  KAKENHI-PROJECT-21H02995
[Presentation] A novel affinity-enhanced NY-ESO-1-targeting TCR-redirected T cell transfer exhibited early-onset cytokine release syndrome and subsequent tumor responses in synovial sarcoma patients.2019
- Author(s)
  Hattori H, Ishihara M, Kitano S, Miyahara Y, Kato H, Mishima H, Yamamoto N, Funakoshi T, Kojima T, Sasada T, Sato E, Okamoto S, Tomura D, Chono H, Nukaya I, Mineno J, Ikeda H, Watanabe T, Kageyama S, Shiku H.
- Organizer
  ESMO 2019 Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] Changes of BCR Repertoire Are Predictive Biomarker for the Efficacy of Immune Checkpoint Inhibitor in NSCLC.2019
- Author(s)
  Azuma K, Nakahara Y, Matsuo N, Ishii H, Tokito T, Murotani K, Hoshino T, Sasada T.
- Organizer
  2019 World Conference on Lung Cancer
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] Tumor responses and early onset cytokine release syndrome in synovial sarcoma patients treated with a novel affinity-enhanced NY-ESO-1-targeting TCR-redirected T cell transfer.2019
- Author(s)
  Ishihara M, Kitano S, Hattori H, Miyahara Y, Kato H, Mishima H, Yamamoto N, Funakoshi T, Kojima T, Sasada T, Sato E, Okamoto S, Tomura D, Chono H, Nukaya I, Mineno J, Ikeda H, Watanabe T, Kageyama S, Shiku H.
- Organizer
  ASCO Annual Meeting 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Immunogenicity of frequent driver mutations; identification of novel HLA class II-restricted neoantigens.2019
- Author(s)
  Susumu Iiizumi, Junya Ohtake, Taku Kouro, Mamoru Kawahara, Yuka Igarashi, Norihiro Nakamura, Tetsuro Sasada.
- Organizer
  第23回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] Proteogenomics-based identifying neoantigens in refractory cancers using xenograft mice.2019
- Author(s)
  Yuko Nakamura, Susumu Iizumi, Hiroki Ueda, Shogo Yamamoto, Kenji Tatsuno, Aya Nakayama, Kazuki Yamamoto, Taku Koro, Kyoko Hasegawa, Norihiro Nakamura, Hiroyuki Aburatani, Tetsuro Sasada, Takeshi Kawamura.
- Organizer
  18th Human Proteome Organization World Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] Immunogenicity of frequent driver mutations; identification of novel HLA class II-restricted neoantigens.2019
- Author(s)
  Susumu Iiizumi, Junya Ohtake, Taku Kouro, Mamoru Kawahara, Yuka Igarashi, Norihiro Nakamura, Tetsuro Sasada.
- Organizer
  第23回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Early changes in plasma CXCL2 and MMP2 levels predicts the response to anti-PD-1 therapy in non-small-cell lung cancer.2019
- Author(s)
  Matsuo N, Azuma K, Murotani K, Ishii H, Tokito T, Yamada K,Shibata Y, Shimokawaji T, Nakahara Y, Kondo T, Kato T, Saito H, Yamada K, Sasada T, Hoshino T.
- Organizer
  2019 World Conference on Lung Cancer
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Changes in plasma CXCL2 and MMP2 levels reflect response to anti-PD-1 therapy in non-small-cell lung cancer patients.2019
- Author(s)
  Norikazu Matsuo, Koichi Azuma, Kenta Murotani, Yoshiko Naito, Hidenobu Ishii, Takaaki Tokito, Tadasuke Shimokawaji, Yoshiro Nakahara, Tetsuro Kondo, Terufumi Kato Haruhiro Saito, Kouzo Yamada, Tetsuro Sasada, Tomoaki Hoshino.
- Organizer
  第17回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] A novel affinity-enhanced NY-ESO-1-targeting TCR-redirected T cell transfer exhibited early-onset cytokine release syndrome and subsequent tumor responses in synovial sarcoma patients.2019
- Author(s)
  Hattori H, Ishihara M, Kitano S, Miyahara Y, Kato H, Mishima H, Yamamoto N, Funakoshi T, Kojima T, Sasada T, Sato E, Okamoto S, Tomura D, Chono H, Nukaya I, Mineno J, Ikeda H, Watanabe T, Kageyama S, Shiku H.
- Organizer
  ESMO 2019 Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Optimization of CAR T cells recognizing malignant mesothelioma specific antigen.2019
- Author(s)
  Taku Kouro, Kohzoh Imai, Tetsuro Sasada.
- Organizer
  第48回日本免疫学会学術集会
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] High expression of Olfactomedin-4 correlates with chemoresistance and poor prognosis for pancreatic cancer.2019
- Author(s)
  Ryotaro Ohkuma, Erica Yada, Yutaro Kubota, Kazuyuki Hamada, Hiroo Ishida, Yuya Hirasawa, Hirotsugu Ariizumi, Etsuko Satoh, Junji Tsurutani, Kiyoshi Yoshimura, Tetsuro Sasada, Takeshi Aoki, Masahiko Murakami, Tomoko Norose, Nobuyuki Ohike, Masafumi Takimoto, Takuya Tsunoda, Satoshi Wada.
- Organizer
  AACR Annual Meeting 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Optimization of chimeric antigen receptor construct targeting malignant mesothelioma antigen.2019
- Author(s)
  Taku Kouro, Shoutaro Tsuji, Kohzoh Imai, Tetsuro Sasada.
- Organizer
  第78回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Enhanced lymphocyte accumulation through chemokine overexpression in tumor microenvironment.2019
- Author(s)
  Yuka Igarashi, Junya Ohtake, Yuki Fujimoto, Tetsuro Sasada.
- Organizer
  第48回日本免疫学会学術集会
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] Immunogenicity of HLA class II-restricted neoantigens derived from driver mutations.2019
- Author(s)
  Sasada T, Iiizumi S, Kouro T, Kawahara M, Nakamura N.
- Organizer
  Fifth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] Changes in plasma CXCL2 and MMP2 levels reflect response to anti-PD-1 therapy in non-small-cell lung cancer patients.2019
- Author(s)
  Norikazu Matsuo, Koichi Azuma, Kenta Murotani, Yoshiko Naito, Hidenobu Ishii, Takaaki Tokito, Tadasuke Shimokawaji, Yoshiro Nakahara, Tetsuro Kondo, Terufumi Kato Haruhiro Saito, Kouzo Yamada, Tetsuro Sasada, Tomoaki Hoshino.
- Organizer
  第17回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] High expression of Olfactomedin-4 correlates with chemoresistance and poor prognosis for pancreatic cancer.2019
- Author(s)
  Ryotaro Ohkuma, Erica Yada, Yutaro Kubota, Kazuyuki Hamada, Hiroo Ishida, Yuya Hirasawa, Hirotsugu Ariizumi, Etsuko Satoh, Junji Tsurutani, Kiyoshi Yoshimura, Tetsuro Sasada, Takeshi Aoki, Masahiko Murakami, Tomoko Norose, Nobuyuki Ohike, Masafumi Takimoto, Takuya Tsunoda, Satoshi Wada.
- Organizer
  AACR Annual Meeting 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] Enhanced lymphocyte accumulation through chemokine overexpression in tumor microenvironment.2019
- Author(s)
  Yuka Igarashi, Junya Ohtake, Yuki Fujimoto, Tetsuro Sasada.
- Organizer
  第48回日本免疫学会学術集会
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Early changes in plasma CXCL2 and MMP2 levels predicts the response to anti-PD-1 therapy in non-small-cell lung cancer.2019
- Author(s)
  Matsuo N, Azuma K, Murotani K, Ishii H, Tokito T, Yamada K,Shibata Y, Shimokawaji T, Nakahara Y, Kondo T, Kato T, Saito H, Yamada K, Sasada T, Hoshino T.
- Organizer
  2019 World Conference on Lung Cancer
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] Changes of BCR Repertoire Are Predictive Biomarker for the Efficacy of Immune Checkpoint Inhibitor in NSCLC.2019
- Author(s)
  Azuma K, Nakahara Y, Matsuo N, Ishii H, Tokito T, Murotani K, Hoshino T, Sasada T.
- Organizer
  2019 World Conference on Lung Cancer
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Optimization of chimeric antigen receptor construct targeting malignant mesothelioma antigen.2019
- Author(s)
  Taku Kouro, Shoutaro Tsuji, Kohzoh Imai, Tetsuro Sasada.
- Organizer
  第78回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] Changes of BCR repertoire are predictive biomarker for the efficacy of immune checkpoint inhibitor in NSCLC.2019
- Author(s)
  Yoshiro Nakahara, Norikazu Matsuo, Koichi Azuma, Yoshiko Naito, Hidenobu Ishii, Takaaki Tokito, Yuka Igarashi, Taku Kouro, Ryo Usui, Tadasuke Shimokawaji, Tetsuro Kondo, Terufumi Kato, Haruhiro Saito, KouzoYamada, Tomoaki Hoshino, Tetsuro Sasada.
- Organizer
  第17回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Tumor responses and early onset cytokine release syndrome in synovial sarcoma patients treated with a novel affinityenhanced NY-ESO-1-targeting TCR-redirected T cell transfer.2019
- Author(s)
  Ishihara M, Kitano S, Hattori H, Miyahara Y, Kato H, Mishima H, Yamamoto N, Funakoshi T, Kojima T, Sasada T, Sato E, Okamoto S, Tomura D, Chono H, Nukaya I, Mineno J, Ikeda H, Watanabe T, Kageyama S, Shiku H.
- Organizer
  ASCO Annual Meeting 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] B細胞受容体(BCR)のレパトア解析は非小細胞肺がんにおける免疫チェックポイント阻害剤のバイオマーカーとして有用である.2019
- Author(s)
  五十嵐友香, 中原善朗, 松尾規和, 東公一, 笹田哲朗.
- Organizer
  第23回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] B細胞受容体(BCR)のレパトア解析は非小細胞肺がんにおける免疫チェックポイント阻害剤のバイオマーカーとして有用である2019
- Author(s)
  五十嵐友香, 中原善朗, 松尾規和, 東公一, 笹田哲朗
- Organizer
  第23回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] Changes of BCR repertoire are predictive biomarker for the efficacy of immune checkpoint inhibitor in NSCLC.2019
- Author(s)
  Yoshiro Nakahara, Norikazu Matsuo, Koichi Azuma, Yoshiko Naito, Hidenobu Ishii, Takaaki Tokito, Yuka Igarashi, Taku Kouro, Ryo Usui, Tadasuke Shimokawaji, Tetsuro Kondo, Terufumi Kato, Haruhiro Saito, Kouzo Yamada, Tomoaki Hoshino, Tetsuro Sasada.
- Organizer
  第17回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] Optimization of CAR T cells recognizing malignant mesothelioma specific antigen.2019
- Author(s)
  Taku Kouro, Kohzoh Imai, Tetsuro Sasada.
- Organizer
  第48回日本免疫学会学術集会
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] Proteogenomics-based identifying neoantigens in refractory cancers using xenograft mice.2019
- Author(s)
  Yuko Nakamura, Susumu Iizumi, Hiroki Ueda, Shogo Yamamoto, Kenji Tatsuno, Aya Nakayama, Kazuki Yamamoto, Taku Koro, Kyoko Hasegawa, Norihiro Nakamura, Hiroyuki Aburatani, Tetsuro Sasada, Takeshi Kawamura.
- Organizer
  18th Human Proteome Organization World Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Immunogenicity of HLA class II-restricted neoantigens derived from driver mutations.2019
- Author(s)
  Sasada T, Iiizumi S, Kouro T, Kawahara M, Nakamura N.
- Organizer
  Fifth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Elucidation of immunosuppressive microenvironment in colorectal cancer.2018
- Author(s)
  Sasada T, Ohtake J, Satoyoshi T, Kazama K, Wada S, Yada E, Shiozawa M.
- Organizer
  AACR Annual Meeting 2018
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Generation of CAR T cells recognizing malignant mesothelioma specific antigen.2018
- Author(s)
  Taku Kouro, Erica Yada, Mamoru Kawahara, Kozo Imai, Tetsuro Sasada.
- Organizer
  第47回日本免疫学会学術集会
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Inflammatory soluble factors as potential biomarkers in non-small cell lung cancer treated with anti-PD-1 inhibitors.2018
- Author(s)
  Tetsuro Sasada, Norikazu Matsuo, Junya Ohtake, Koichi Azuma.
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Identification of therapeutic-specific mutations induced by anti-cancer drug using pancreatic cancer xenograft.2018
- Author(s)
  Erica Yada, Tetsuro Sasada, Satoshi Wada.
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Potential biomarkers in non-small cell lung cancer patients treated with anti-PD-1 inhibitors.2018
- Author(s)
  Norikazu Matsuo, Koichi Azuma, Junya Ohtake, Tetsuro Sasada.
- Organizer
  第22回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] Immunogenicity and specificity of neoantigens derived from tumor-specific mutations in gastric cancer.2018
- Author(s)
  Sasada T, Ohtake J, Iizumi S, Kouro T, Igarashi Y, Kawahara M, Yada E.
- Organizer
  The 33rd Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2018)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] Identification of therapeutic-specific mutations induced by anti-cancer drug using pancreatic cancer xenograft.2018
- Author(s)
  Erica Yada, Tetsuro Sasada, Satoshi Wada.
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] Potential biomarkers in non-small cell lung cancer patients treated with anti-PD-1 inhibitors.2018
- Author(s)
  Norikazu Matsuo, Koichi Azuma, Junya Ohtake, Tetsuro Sasada.
- Organizer
  第22回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Identification of therapeutic-specific mutations induced by gemcitabine and nab-Paclitaxel in pancreatic cancer.2018
- Author(s)
  Erica Yada, Taku Kouro,Tetsuro Sasada, Satoshi Wada.
- Organizer
  第47回日本免疫学会学術集会
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] Immunogenicity and specificity of neoantigens derived from tumor-specific mutations in gastric cancer.2018
- Author(s)
  Sasada T, Ohtake J, Iizumi S, Kouro T, Igarashi Y, Kawahara M, Yada E.
- Organizer
  The 33rd Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2018)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Inflammatory soluble factors as potential biomarkers in non-small cell lung cancer treated with anti-PD-1 inhibitors.2018
- Author(s)
  Tetsuro Sasada, Norikazu Matsuo, Junya Ohtake, Koichi Azuma.
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] Generation of CAR T cells recognizing malignant mesothelioma specific antigen2018
- Author(s)
  Taku Kouro, Erica Yada, Mamoru Kawahara, Kozo Imai, Tetsuro Sasada.
- Organizer
  第47回日本免疫学会学術集会
- Data Source
  KAKENHI-PROJECT-18K19490
[Presentation] Identification of therapeutic-specific mutations induced by gemcitabine and nab-Paclitaxel in pancreatic cancer.2018
- Author(s)
  Erica Yada, Taku Kouro,Tetsuro Sasada, Satoshi Wada.
- Organizer
  第47回日本免疫学会学術集会
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] 乳がんに対するワクチン療法の現状と展望.2018
- Author(s)
  笹田哲朗.
- Organizer
  第26回日本乳癌学会学術総会ワークショップ「腫瘍免疫：基礎から臨床へ」
- Invited
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Comprehensive analysis of immunological tumor environment in colorectal cancer2017
- Author(s)
  Junya Ohtake, Tetsuta Satoyoshi, Keisuke Kazama, Satoshi Wada, Erika Yada, Hiromi Mikami, Shintaro Yoshida, Manabu Shiozawa, Tetsuro Sasada
- Organizer
  第46回日本免疫学会学術集会
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] 大腸がんにおける免疫細胞の形質・機能の解析と免疫抑制機構の解明2017
- Author(s)
  大竹淳矢、里吉哲太、和田聡、矢田英理香、三神裕美、吉田慎太郎、塩沢学、笹田哲朗
- Organizer
  第21回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-16K15601
[Presentation] Elucidation of potential immune suppressive mechanisms in colorectal cancer2017
- Author(s)
  Junya Ohtake, Tetsuta Satoyoshi, Satoshi Wada, Erika Yada, Hiromi Mikami, Shintaro Yoshida, Manabu Shiozawa, Tetsuro Sasada
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Elucidation of potential immune suppressive mechanisms in colorectal cancer2017
- Author(s)
  Junya Ohtake, Tetsuta Satoyoshi, Satoshi Wada, Erika Yada, Hiromi Mikami, Shintaro Yoshida, Manabu Shiozawa, Tetsuro Sasada
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-16K15601
[Presentation] 大腸がんにおける免疫細胞の形質・機能の解析と免疫抑制機構の解明2017
- Author(s)
  大竹淳矢、里吉哲太、和田聡、矢田英理香、三神裕美、吉田慎太郎、塩沢学、笹田哲朗
- Organizer
  第21回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Comprehensive analysis of T cells responsive to neoantigens derived from tumor-specific genetic mutations2017
- Author(s)
  Tetsuro Sasada, Junya Ohtake, Satoshi Wada, Erika Yada, Shintaro Yoshida
- Organizer
  AACR Annual Meeting 2017
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K15601
[Presentation] Comprehensive analysis of T cells responsive to neoantigens derived from tumor-specific genetic mutations.2017
- Author(s)
  Tetsuro Sasada, Junya Ohtake, Satoshi Wada, Erika Yada, Shintaro Yoshida
- Organizer
  AACR Annual Meeting 2017
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04278
[Presentation] Comprehensive analysis of immunological tumor environment in colorectal cancer2017
- Author(s)
  Junya Ohtake, Tetsuta Satoyoshi, Keisuke Kazama, Satoshi Wada, Erika Yada, Hiromi Mikami, Shintaro Yoshida, Manabu Shiozawa, Tetsuro Sasada
- Organizer
  第46回日本免疫学会学術集会
- Data Source
  KAKENHI-PROJECT-16K15601
[Presentation] Comprehensive analysis of T cell responses specific to neoantigens derived from gene mutations.2016
- Author(s)
  Junya Ohtake, Satoshi Wada, Erica Yada, Yuki Fujimoto, Hidemi Uchiyama, Shintaro Yoshida, Tetsuro Sasada.
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  神奈川県横浜市
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-16K15601
[Presentation] 突然変異遺伝子に対する特異的Ｔ細胞反応の網羅的解析2016
- Author(s)
  大竹淳矢、和田聡、矢田英理香、藤本佑希、内山秀美、吉田慎太郎、笹田哲朗
- Organizer
  第20回日本がん免疫学会総会
- Place of Presentation
  大阪府大阪市
- Year and Date
  2016-07-28
- Data Source
  KAKENHI-PROJECT-26293293
[Presentation] Establishment of pancreatic patient-derived xenograft (PDX).2016
- Author(s)
  Erica Yada, Junya Ohtake, Tetsuro Sasada, Satoshi Wada.
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  神奈川県横浜市
- Year and Date
  2016-10-07
- Data Source
  KAKENHI-PROJECT-26293293
[Presentation] 突然変異遺伝子に対する特異的T細胞反応の網羅的解析2016
- Author(s)
  大竹淳矢、和田聡、矢田英理香、藤本佑希、内山秀美、吉田慎太郎、笹田哲朗
- Organizer
  第20回日本がん免疫学会総会
- Place of Presentation
  大阪府大阪市
- Year and Date
  2016-07-28
- Data Source
  KAKENHI-PROJECT-16K15601
[Presentation] High immunogenicity of neoantigens derived from tumor-specific gene mutations.2016
- Author(s)
  Junya Ohtake, Satoshi Wada, Erica Yada, Yuki Fujimoto, Hidemi Uchiyama, Shintaro Yoshida, Tetsuro Sasada.
- Organizer
  第45回日本免疫学会学術集会
- Place of Presentation
  沖縄県宜野湾市
- Year and Date
  2016-12-06
- Data Source
  KAKENHI-PROJECT-16K15601
[Presentation] Comprehensive analysis of T cell responses specific to neoantigens derived from gene mutations.2016
- Author(s)
  Junya Ohtake, Satoshi Wada, Erica Yada, Yuki Fujimoto, Hidemi Uchiyama, Shintaro Yoshida, Tetsuro Sasada.
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  神奈川県横浜市
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26293293
[Presentation] Establishment of pancreatic patient-derived xenograft (PDX).2016
- Author(s)
  Erica Yada, Junya Ohtake, Tetsuro Sasada, Satoshi Wada.
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  神奈川県横浜市
- Year and Date
  2016-10-07
- Data Source
  KAKENHI-PROJECT-16K15601
[Presentation] 膵臓がんゼノグラフトの有用性の検証　～治療の新規標的分子の探索に向けて～2016
- Author(s)
  矢田英理香、大竹淳矢、吉田慎太郎、藤本佑希、内山秀美、笹田哲朗、和田聡
- Organizer
  第20回日本がん免疫学会総会
- Place of Presentation
  大阪府大阪市
- Year and Date
  2016-07-28
- Data Source
  KAKENHI-PROJECT-16K15601
[Presentation] High immunogenicity of neoantigens derived from tumor-specific gene mutations.2016
- Author(s)
  Junya Ohtake, Satoshi Wada, Erica Yada, Yuki Fujimoto, Hidemi Uchiyama, Shintaro Yoshida, Tetsuro Sasada.
- Organizer
  第45回日本免疫学会学術集会
- Place of Presentation
  沖縄県宜野湾市
- Year and Date
  2016-12-06
- Data Source
  KAKENHI-PROJECT-26293293
[Presentation] 膵臓がんゼノグラフトの有用性の検証　～治療の新規標的分子の探索に向けて～2016
- Author(s)
  矢田英理香、大竹淳矢、吉田慎太郎、藤本佑希、内山秀美、笹田哲朗、和田聡
- Organizer
  第20回日本がん免疫学会総会
- Place of Presentation
  大阪府大阪市
- Year and Date
  2016-07-28
- Data Source
  KAKENHI-PROJECT-26293293
[Presentation] 肝硬変に対する脾摘の生体防御機構に与える影響.2015
- Author(s)
  平川雄介、緒方俊郎、笹田哲朗、田中将也、谷口雅彦、鹿毛政義、奥田康司、田中啓之.
- Organizer
  2015年度日本消化器関連学会週間（JDDW 2015）
- Place of Presentation
  グランドプリンスホテル新高輪（東京）
- Year and Date
  2015-10-09
- Data Source
  KAKENHI-PROJECT-26293293
[Presentation] Clinical Significance of Tumor-Associated Tertiary Lymphoid Structures in Pancreatic Cancer.2015
- Author(s)
  Sasada T, Suekane S, Reinherz EL.
- Organizer
  13th CIMT (The Association for Cancer Immunotherapy) Annual Meeting.
- Place of Presentation
  Mainz（Germany）
- Year and Date
  2015-05-11
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26293293
[Presentation] 肝硬変に対する脾摘の生体防御/抗腫瘍免疫機構に与える影響2015
- Author(s)
  平川雄介、緒方俊郎、笹田哲朗、田中将也、谷口雅彦、鹿毛政義、奥田康司、田中啓之.
- Organizer
  第22回日本門脈圧亢進症学会総会
- Place of Presentation
  パシフィコ横浜（横浜）
- Year and Date
  2015-09-11
- Data Source
  KAKENHI-PROJECT-26293293
[Presentation] Feasibility studies of personalized peptide vaccination for advanced gynecologic cancer patients.2015
- Author(s)
  Waki K, Kawano K, Sasada T, Ushijima K, ItohK, Kamura T, Yamada A.
- Organizer
  第74回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場（名古屋）
- Year and Date
  2015-10-10
- Data Source
  KAKENHI-PROJECT-26293293
[Presentation] The feasibility of personalized peptide vaccination for previously treated advanced colorectal cancer; A phase II Study.2015
- Author(s)
  Akagi Y, Kibe S, Yutani S, Motoyama S, Nomura T, Kawahara A, Yamaguchi T, Matsueda S, Komatsu N, Miura M, Hinai Y, Hattori S, Yamada A, Kage M, Itoh K, Sasada T.
- Organizer
  ESSR (European Society for Surgical Research) 2015.
- Place of Presentation
  Liverpool（England）
- Year and Date
  2015-06-10
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26293293
[Presentation] がん免疫療法の現状と今後の展望2015
- Author(s)
  笹田哲朗
- Organizer
  日本薬物動態学会第30回年会シンポジウム
- Place of Presentation
  タワーホール船堀（東京）
- Year and Date
  2015-11-14
- Invited
- Data Source
  KAKENHI-PROJECT-26293293
[Presentation] Phase II Clinical Trial of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer.2014
- Author(s)
  Sasada T, Yutani S, Kibe S, Matsueda S, Komatsu K, Yamada A, Akagi Y, Itoh K.
- Organizer
  12th CIMT (The Association for Cancer Immunotherapy) Annual Meeting.
- Place of Presentation
  Mainz, Germany
- Year and Date
  2014-05-06
- Data Source
  KAKENHI-PROJECT-26293293
[Presentation] Randomized phase II study of personalized peptide vaccination with cyclophosphamide pretreatment in refractory advanced biliary tract cancer patients.2014
- Author(s)
  Sasada T, Yutani S, Matsueda S, Shirahama T, Yamada A, Itoh K.
- Organizer
  2014 ASCO Annual Meeting.
- Place of Presentation
  Chicago, IL, USA
- Year and Date
  2014-06-01
- Data Source
  KAKENHI-PROJECT-26293293
[Presentation] 標準治療抵抗性大腸癌に対するテーラーメイド癌ペプチドワクチン療法の検討2013
- Author(s)
  山田哲平、笹田哲朗、伊東恭悟
- Organizer
  第117回日本外科学会定期学術集会
- Place of Presentation
  福岡市
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] EGFR T790M-derived T Cell Epitopes as a Target for Immunotherapy against EGFR-TKI-resistant Non-Small Cell Lung Cancer2013
- Author(s)
  Yamada T, Sasada T, et al.
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜市
- Year and Date
  2013-10-05
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] Association of haptoglobin genetic polymorphism with overall survival in advanced castration-resistant prostate cancer patients with personalized peptide vaccination.2013
- Author(s)
  Komatsu N, Pang X, Araki H, Koda Y, Soejima K, Sasada T, Tashiro K, Kuhara S, Itoh1 K.
- Organizer
  28th Annual Meeting of Society for Immunotherapy of Cancer (SITC).
- Place of Presentation
  National Harbor, MD, USA
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] EGFR T790M mutation as a novel target for immunotherapy against EGFR-TKI-resistant non-small cell lung cancer.2013
- Author(s)
  Sasada T, Yamada T, Azuma K, Matsueda S, Itoh K.
- Organizer
  28th Annual Meeting of Society for Immunotherapy of Cancer (SITC).
- Place of Presentation
  National Harbor, MD, USA
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] 膵臓癌に対する十全大補湯のテーラーメイドペプチドワクチン療法への免疫増強効果の検討2013
- Author(s)
  山田哲平、笹田哲朗、伊東恭悟
- Organizer
  第68回日本消化器外科学会総会
- Place of Presentation
  宮崎市
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] 去勢抵抗性前立腺がんに対するペプチドワクチン療法2013
- Author(s)
  野口正典、末金茂高、守屋普久子、笹田哲朗、山田　亮、伊東恭悟
- Organizer
  第11回日本臨床腫瘍学会学術総会
- Place of Presentation
  仙台市
- Invited
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] Phase II study of personalized peptide vaccination for cisplatin-based chemotherapy resistant advanced urothelial carcinoma patients.2013
- Author(s)
  Suekane S, Noguchi M, Moriya F, Sasada T, Matsuoka K Itoh K.
- Organizer
  2013 AUA Annual Meeting
- Place of Presentation
  San Diego, CA, USA
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] EGFR T790M Mutation as a Novel Target for Immunotherapy against EGFR-TKI-resistant Non-Small Cell Lung Cancer2013
- Author(s)
  Yamada T, Sasada T, et al.
- Organizer
  第17回日本がん免疫学会総会
- Place of Presentation
  宇部市
- Year and Date
  2013-07-05
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] Phase I trial of a novel cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer.2013
- Author(s)
  Noguchi M, Arai G, Matsumoto K, Naito S, Moriya F, Suekane S, Sasada T, Yamada A, Itoh K.
- Organizer
  33rd Congress of the Societe Internationale d’Urologie (SIU).
- Place of Presentation
  Vancouver, BC, USA
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] 去勢抵抗性前立腺がんに対するペプチドワクチン療法2013
- Author(s)
  野口正典、末金茂高、守屋普久子、笹田哲朗、山田　亮、伊東恭悟
- Organizer
  第78回日本泌尿器科学会東部総会
- Place of Presentation
  新潟市
- Invited
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] EGFR T790M mutation as a novel target for immunotherapy against EGFR-TKI-resistant non-small cell lung cancer2013
- Author(s)
  Sasada T, et al.
- Organizer
  28th Annual Meeting of Society for Immunotherapy of Cancer (SITC)
- Place of Presentation
  National Harbor, MD, USA
- Year and Date
  2013-11-08
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] Personalized peptide vaccination in combination with chemotherapyfor patients with advanced colorectal cancer.2012
- Author(s)
  Tetsuro Sasada,Shigeru Yutani, Satoko Matsueda, Nobukazu Komatsu, Kyogo Itoh.
- Organizer
  Society for Immunotherapy of Cancer (SITC) 2012 Meeting
- Place of Presentation
  North Bethesda, USA
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] Identification of Predoctive Biomarkers in cancer patients receiving personalized peptide vaccination2011
- Author(s)
  笹田哲朗、松枝智子、七條茂樹、小松誠和、五百路徹也、野口正典、山田亮、伊東恭悟
- Organizer
  第15回日本癌免疫学会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] Identification of Predictive Biomarkers in Cancer Patients Receiving Personalized Peptide Vaccination.2011
- Author(s)
  Sasada T, Matsueda S, Shichijo S, Ioji T, Komatsu N, Noguchi M, Yamada A, Itoh K.
- Organizer
  26th Annual Meeting of Society for Immunotherapy of Cancer.
- Place of Presentation
  Bethesda, MD, USA
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] Predictive Biomarker in Cancer Patients Receiving Personalized Peptide Vaccination.2011
- Author(s)
  Sasada T, Matsueda S, Shichijo S, Komatsu N, Noguchi M, Yamada A, Itoh K.
- Organizer
  第70回日本癌学会総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] GENE EXPRESSION PROFILING USEFUL FOR PREDICTING CLINICAL RESPONSES TO PERSONALIZED PEPTIDE VACCINATION.2010
- Author(s)
  Sasada T
- Organizer
  25^<th> International Society for Biological Therapy of Cancer
- Place of Presentation
  米国ワシントンDC
- Year and Date
  2010-10-02
- Data Source
  KAKENHI-PROJECT-22890229
[Presentation] 再燃前立腺がんを対象としたテーラーメイドペプチドワクチン療法における一塩基多型(SNPs)解析による予後予測マーカーの探索
- Author(s)
  小松誠和、Xiaoliang Pang、荒木啓充、高木真理、宮田有英、松枝智子、笹田哲朗、田代康介、久原哲、伊東恭悟
- Organizer
  第17回日本がん免疫学会総会
- Place of Presentation
  宇部市
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] 標準治療抵抗性の進行膵癌に対するテーラーメイド型ペプチドワクチン療法
- Author(s)
  笹田哲朗、吉富宗宏、由谷茂、伊東恭悟
- Organizer
  第67回日本消化器外科学会総会
- Place of Presentation
  富山市
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] EGFR T790M Mutation as a Novel Target for Immunotherapy against EGFR-TKI-resistant Non-Small Cell Lung Cancer.
- Author(s)
  Teppei YAMADA, Koichi AZUMA, Shunichi SUGAWARA, Satoko MATSUEDA, Yuichi YAMASHITA, Kyogo ITOH, Tetsuro SASADA
- Organizer
  第17回日本がん免疫学会総会
- Place of Presentation
  宇部市
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] 去勢抵抗性前立腺がん患者を対象とした20ペプチド混合ワクチンの第1相臨床試験
- Author(s)
  山田亮、野口正典、笹田哲朗、小松誠和、松枝智子、伊東恭悟
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜市
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] テーラーメイドがんペプチドワクチン：進行がんに対する新規免疫療法
- Author(s)
  笹田哲朗、野口正典、山田亮、小松誠和、松枝智子、伊東恭悟
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  札幌市
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] Personalized peptide vaccination as the second line therapy for patients with chemotherapy-resistant advanced pancreatic cancer.
- Author(s)
  Tetsuro Sasada, Shigeru Yutani, Munehiro Yoshitomi, Satoko Matsueda, Nobukazu Komatsu, Kyogo Itoh.
- Organizer
  American Association for Cancer Research　(AACR) Annual Meeting 2012
- Place of Presentation
  Chicago, USA
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] 乳癌テーラーメイドペプチドワクチン療法後の免疫組織学的検討
- Author(s)
  唐宇飛、高橋龍司、岩熊伸高、竹中美貴、高良慶子、白水和雄、松枝智子、笹田哲朗、伊東恭悟
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜市
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] CTLエピトープワクチン療法
- Author(s)
  伊東恭悟、山田亮、植村天受、笹田哲朗、野口正典
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜市
- Invited
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] 癌ペプチドワクチン療法における新規バイオマーカーの探索
- Author(s)
  笹田哲朗、伊東恭悟
- Organizer
  第112回日本外科学会総会
- Place of Presentation
  千葉市
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] EGFR T790M-derived T Cell Epitopes as a Target for Immunotherapy against EGFR-TKI-resistant Non-Small Cell Lung Cancer
- Author(s)
  Teppei Yamada, Koichi Azuma, Shunichi Sugawara, Satoko Matsueda, Yuichi Yamashita, Kyogo Itoh, Tetsuro Sasada
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜市
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] ヒトパピローマウイルス様粒子ワクチン投与により免疫原性を示すHPV16型L1由来ペプチドエピトープの同定
- Author(s)
  松枝智子、横峯正人、福井章正、河野光一郎、津田尚武、七條茂樹、笹田哲朗、牛島公生、伊東恭悟、嘉村敏治
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜市
- Data Source
  KAKENHI-PROJECT-23591913
[Presentation] 再燃前立腺がん患者の遺伝子発現プロファイルに基づくテーラーメイドペプチドワクチン適格性診断マーカーの同定
- Author(s)
  荒木啓充、Pang Xiaoliang、高木真理、宮田有英、小松誠和、松枝智子、伊東恭悟、笹田哲朗、田代康介、久原哲
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  横浜市
- Data Source
  KAKENHI-PROJECT-23591913

1. MATSUEDA Satoko (60610582)

# of Collaborated Projects: 1 results

# of Collaborated Products: 14 results
2. TAKABAYASHI Arimichi (00226911)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. NAKAMURA Hajime (70303914)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 田代康介 (00192170)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 大竹淳矢 (10758915)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
6. 岸裕幸 (60186210)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
7. 東公一 (00368896)

# of Collaborated Projects: 1 results

# of Collaborated Products: 9 results
8. 紅露拓 (90372424)

# of Collaborated Projects: 1 results

# of Collaborated Products: 10 results
9. 星野大輔 (30571434)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
10. 川村猛 (70306835)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
11. 上田宏生 (70821916)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
12. 魏菲菲 (50833969)

# of Collaborated Projects: 1 results

# of Collaborated Products: 9 results
13. MATSUMOTO Kazumasa

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
14. 野口正典

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
15. 小松誠和

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
16. 副島美貴子

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
17. 神田芳郎

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
18. 和田聡

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
19. 山田亮

# of Collaborated Projects: 0 results

# of Collaborated Products: 8 results
20. 末金茂高

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
21. 伊東恭悟

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
22. 植田浩介

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
23. 七條茂樹

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
24. 唐宇飛

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
25. 項慧慧

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
26. 関直子

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
27. 齋藤菜緒

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
28. 吉川聡明

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
29. 氷室秀知

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
30. 影山慎一

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
31. 宮原慶裕

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
32. 上羽哲也

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
33. 高田弘一

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Sasada Tetsuro 笹田 哲朗

笹田 哲朗 ササダ テツロウ

SASADA Tetsuro 笹田 哲朗

SASADA Teturo 笹田 哲朗

Research Projects

Research Products

Co-Researchers

ペプチドミクス解析とシングルセルTCR解析を用いたネオアンチゲン同定法の確立Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Establishment of an AI-based platform for predicting response to cancer immunotherapy

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Identification of cancer-specific neoantigens in organoid culturePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Analysis of B cell repertoires and their antigen specificity in peripheral blood from cancer patients undergoing anti-PD-1 antibody therapy.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Analysis of neoantigen-specific anti-tumor immune responses and its clinical application for personalized cancer immunotherapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Induction of tumor infiltrating immune cells through regulation of tumor microenvironment and its application for novel cancer immunotherapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Comprehensive analysis of immune responses to tumor-specific genetic mutations and its application to novel cancer immunotherapy.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of Novel Cancer Immunotherapy Targeting Mutated Genes: Identification of Antigen Epitopes Derived from the Mutated KRAS and EGFR Genes.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

上皮間葉移行(EMT)を起こした幹細胞様癌細胞を標的とした新しい免疫療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

リンパ管新生因子を標的としたワクチン療法による癌リンパ節転移予防・治療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Idenification of tumor antigens in pancreatic cancer by proteomic analysis.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of the effect of surgical stress on the biological defense system and cancer promotion

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] プレシジョン・メディシン ～ビッグデータの構築・分析から臨床応用・課題まで～. （第2編 第3章 第3節）変異遺伝子を標的とした個別化がん免疫療法の開発.2018

Sasada Tetsuro 笹田哲朗

笹田哲朗ササダテツロウ

SASADA Tetsuro 笹田哲朗

SASADA Teturo 笹田哲朗

[Book] プレシジョン・メディシン　～ビッグデータの構築・分析から臨床応用・課題まで～.　（第2編第3章第3節）変異遺伝子を標的とした個別化がん免疫療法の開発.2018

[Book] プレシジョン・メディシン　～ビッグデータの構築・分析から臨床応用・課題まで～.　 (第2編第3章第3節) 変異遺伝子を標的とした個別化がん免疫療法の開発.2018

[Book] がん治療で起こる副作用・合併症の治療法と薬剤開発.　 (第4章 11節) がんワクチン2018

[Book] がん治療で起こる副作用・合併症の治療法と薬剤開発.　（第4章 11節）がんワクチン2018